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Abstract 
Cyclic mechanical loading improves strength and extracellular matrix (ECM) synthesis in tissue 
engineered blood vessels (TEBV). The goal of this project was to design a device to impart cyclic 
circumferential stretch on cell-derived TEBV rings cultured on flexible silicone tubing. Our device 
cyclically displaces water (75 μl volume) to inflate tubing at a frequency of 1 Hz. During static inflation 
tests, the tubing diameter increased by 10±1.6%. TEBV rings were loaded onto silicone tubing and 
subjected to mechanical conditioning for 3-7 days. Our device conditioned samples in an incubator at 
10% distension at a frequency of 1 Hz. Static and conditioned tissues remained viable and 
uncontaminated and exhibited high cell densities and increased thicknesses from 3 to 7 days.
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Chapter 1 – Introduction 
 
Most current technologies used to develop small diameter tissue engineered blood vessels (TEBVs) do 
not meet the clinical needs for a mechanically sound graft without extensive time and conditioning in 
culture. Ideally, autologous tissue engineered vessels or grafts would be cultured in vitro then applied in 
vivo. This concept has motivated researchers to study engineered vessels, and is the basis for this 
project. There are currently a variety of methods for the development of small diameter vasculature; 
however, many current technologies present a number of concerns and limitations. 
Originally, engineers developed synthetic grafts made from materials such as Dacron and 
polytetrafluoroethylene (Zacharias et. al., 1987) in hopes of creating a mechanically sound replacement 
for human tissue. These grafts however are limited to vessels with larger diameters. In vessels smaller 
than 6 mm in inner diameter, the synthetic grafts often failed due to thrombosis (Atala et. al., 2008). 
Thrombosis is the formation of blood clots that occlude the vessel. The synthetic materials used in the 
vascular replacement procedures often initiated an immune response. This response would result in 
high levels of inflammation and failure of the graft (O’Donnell et. al., 1984). In an attempt to improve 
the biocompatibility of these materials, scientists have researched biomaterials that, when combined 
with autologous tissues, could result in biointegration of the graft (Mitchell et. al., 2003). The current 
standard for vessel replacement is the CABG, or coronary artery bypass graft, method. The CABG 
procedure requires a type of graft called an autologous graft. These grafts are sections of blood vessels 
less than 6 mm inner diameter, such as the saphenous vein, which are harvested from the patient. The 
graft is then implanted into the coronary circulation system to redirect flow past the damaged or 
occluded vessels. This approach is viable for ten to twelve years; any longer could result in narrowing of 
the vessel, resulting in a need for a second surgery. (L'Heureux, 2003; Goldman et. al., 2004) 
Tissue engineered blood vessels are a potential solution to the complications that arise from the use of 
the previously mentioned vascular repair approaches. TEBVs are constructed by assembling cells taken 
from the patient into tubular constructs. These constructs can then be implanted into the patient, and in 
theory, should have mechanical properties similar to healthy tissue. Two-dimensional models, such as 
skin grafts, have been successfully created; three dimensional models are currently limited due to the 
samples’ poor structural integrity and low mechanical strength. In order to be deemed successful, TEBVs 
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should be able to withstand physiological loads from blood pressure and fluid dynamics within the body. 
Additionally, the samples must be able to resist tearing, especially during suturing and handling. 
(Mitchell et. al., 2003) 
In 2003, a tissue engineering technique was patented that used a cell sheet-based method that cultured 
fibroblasts and smooth muscle cells (SMCs) around a cylindrical mandrel. The result was a fully 
autologous graft that was capable of withstanding mechanical loads greater than that of blood pressure 
(over 2200 mm Hg) and was tear-resistant. Since the graft was composed of living cells, it was self-
renewing resulting in an increased healing potential. Additionally, the graft was completely biological 
and could be remodeled by the body during the healing process. Remodeling is a response of the cells to 
the mechanical manipulations enacted by the surrounding environment. (L'Heureux, 2003)  
Even though the tissue-based grafts greatly improved on past technologies, concerns and limitations 
remain. This approach used SMCs to improve the graft’s strength. However, while the addition of these 
cells increased the strength they limited the graft’s ability to expand and contract. Postoperative studies 
showed that while implanted, in vivo remodeling of the graft resulted in higher levels of elastin 
(L'Heureux, 2003). Elastin is a protein that acts like a rubber band as it contracts the vessel. In order to 
overcome the stiffness resulting from high levels of SMCs and collagen, it is vital to have enough elastin 
so that the vessel can return to the original diameter during pulsatile and pressurized loads. The elastin 
network also contributes to the long-term success of tissue engineered grafts. If a graft is too stiff, there 
will be a difference between the natural tissue and the graft causing the fluid dynamics to change, thus 
impacting the stream of fluids as they pass through the engineered vessel. The increased failure rate due 
to compliance differentials is seen with synthetic materials as well (Mitchell et. al., 2003). An additional 
concern with the application of SMCs as a means of structural support is that it remains difficult to 
regulate their proliferation once implanted. If the cells proliferate excessively, the graft can actually 
occlude itself resulting in failure. (L'Heureux, 2003)  
Collagen networks are the natural means of vasculature support and can be induced in TEBVs in 
appropriate culture environments. The use of collagen gel-based grafts has been studied as a potential 
means for the reduction of the dependency on SMCs. The collagen gel is easier to control and improves 
the strength of the graft. Similar to the elastin networks, remodeling enzymes promote the synthesis of 
these networks. (Mauck et. al., 2009)  
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In a 2009 study which compared the effectiveness of TEBVs to that of autologous grafts of saphenous 
and mammary arteries, cyclic strains were proven to increase the production of collagen networks, 
which is indicative of higher tensile strength. This study specifically examined burst pressure, suture 
retention strength, and compliance of mechanically conditioned TEBVs in comparison to native 
saphenous veins. (Konig et. al., 2009) 
The TEBVs were superior to the autologous grafts in burst pressure and suture retention, but the 
compliance ratios of the TEBVs were much lower. The long-term study showed that the cells appeared 
to react to their environment and maintain mechanical homeostasis. After six months of implantation, 
the TEBV compliance ratio increased by over 100%, whereas the native tissue samples remained 
constant. This increase in compliance validates the notion that a tissue sample exposed to mechanical 
manipulation is capable of remodeling and improving its mechanical properties. (Konig et. al., 2009) In 
this instance, the body functions as the ideal bioreactor, conditioning the TEBVs through physiological 
cardiac loading while maintaining cell viability. This response to physiological mechanical environments 
provides insight into how mechanical conditioning during culture could result in an improved graft. If 
cells respond to in vivo mechanical manipulation, they should also respond to in vitro loading assuming 
appropriate culturing techniques are maintained. These outcomes acted as the inspiration for the 
development of the in vitro mechanical loading model presented in this paper. 
The Rolle Lab at Worcester Polytechnic Institute (WPI) uses tissue engineered blood vessel rings to 
model the mechanical and physiological properties of complete blood vessels. Rat aortic smooth muscle 
cells (SMCs) are grown in agarose molds over 8 days to form completely cell-derived, three-dimensional 
rings with an inner diameter of 2, 4, or 6 mm. It has also been shown that rings cultured in close 
proximity for an extended period of time could fuse to form a single cohesive tube, demonstrating 
possible future applications for in vivo studies. Furthermore, the rings’ relatively small size and short 
production time allowed us to experiment with greater sample sizes. (Gwyther et. al., 2011) 
The goal of this project was to design a bioreactor that would impart mechanical conditioning on 2 mm 
inner diameter tissue rings from the Rolle Lab. The bioreactor also had to be capable of maintaining 
basic cell culture conditions. It was then our responsibility to conduct an in-depth literature review in 
order to identify the limitations of bioreactors used to mechanically condition tissue constructs. As we 
developed an understanding of the problem, we began compiling a list of objectives and constraints. 
Using a collection of client interview data, we applied these objectives and constraints and created a list 
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of functions and means for our device. These means were then analyzed based on client input, material 
biocompatibility and manufacturability, and projected expenses, and several design alternatives were 
created. The designs were further scrutinized based on the plausibility of component interfaces and the 
availability of materials and manufacturing tools. We were able to determine our final design, which we 
prototyped and evaluated through bench top testing and culture experiments. 
Additionally, sections of this paper examine the effects our device may have on the environment and 
the economy. Finally, future recommendations were made so that future teams could learn from our 
results and conclusions and further develop the device. 
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Chapter 2 – Literature Review 
2.1 Mechanical Conditioning 
2.1.1 Definition 
In order for tissue engineered blood vessels (TEBVs) to function successfully, they must have high 
strength and endurance (Butler et. al., 2009) capable of withstanding the natural forces of the human 
body. These forces include shear stresses due to blood flow, vessel wall expansion and contraction due 
to pressure, as well as longitudinal tension along the vessel (Isenberg et. al., 2006). A diagram of these 
forces is pictured in Figure 1. The goal of mechanical conditioning of tissue engineered blood vessels is 
to mimic these natural in vivo forces while TEBVs are growing in vitro. 
 
Figure 1. Forces experienced within natural blood vessels 
Mechanical conditioning is a widely used method for treating engineered tissue constructs to enhance 
their physical and mechanical properties. Techniques for creating artificial tissues have used various cell 
types, such as smooth muscle and endothelial, as well as differing culture conditions to create grafts 
that emulate native tissue (Isenberg et. al, 2006; Isenberg et. al., 2003). 
Cells are affected by an immense variety of chemical and mechanical stimuli. Bone and muscle cells in 
particular are known to respond to these mechanical stresses in a positive way (Neidlinger-Wilke et. al., 
1995), constantly remodeling based on the stresses they are exposed to. Mechanical stretching of 
smooth muscle cells (SMCs) cultured in collagen-based tissue equivalents has been shown to have 
immense effects on SMC orientation (Dartsch et. al., 1986; Kanda et. al., 1993; Liu, 1998), ECM 
deposition (Chiquet et. al., 1996; Kolpakov et. al., 1995; Kim et. al., 1999; Niklason et. al., 1999; Kulik et. 
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al., 1993), and release of cellular growth factors (Cheng et. al., 1997; Sudhir et. al., 2001). Liu’s 1998 
study found that under circumferential strain, rat blood vessel SMCs arrange themselves in the 
circumferential direction. Kim (1999) found that cyclic mechanical strain (7% distension at 1 Hz for 4 
days) applied to smooth muscle tissue grafted onto polymeric scaffolds increased SMC proliferation and 
collagen and elastin expression. This resulted in enhanced mechanical properties and long term tissue 
organization. Cheng (1997) found that mechanical strain influences fibroblast growth factor-2 (FGF-2) 
release from human SMCs. As the amplitude of deformation rose, more FGF-2 was released in response; 
from 4% amplitude (90 cycles at 1 Hz) releasing 0.1±0.1% FGF-2 to 14% (90 cycles at 1 Hz) releasing 
5.7±0.5% FGF-2.   
In order for engineered musculoskeletal, vascular, and cardiac tissues to function successfully without 
failure in vivo, mechanical modulation must be considered. Ideally, a combination of mechanical and 
biochemical factors will lead to engineered constructs whose functionality and mechanical properties 
closely mimic those of native tissue. Perfecting mechanical conditioning techniques is of the utmost 
importance for cardiovascular tissue engineering before in vivo applications can be seriously considered 
(Rubbens et. al., 2009; Butler et. al., 2009). Mechanical forces are becoming as important as growth 
factors or cytokines in the overall growth and development of TEBVs. (Freed et. al., 2006) 
2.1.2 Impact on TEBV Structure and Properties 
1. Benefits of Mechanical Conditioning 
Naturally occurring vascular SMCs are not exposed directly to shear stress by normal blood flow, they 
are primarily affected by pulsatile distension during the cardiac cycle (Isenberg et. al., 2003). Due to this, 
tissue engineered blood vessels are primarily conditioned based on the dominant stress encountered in 
vivo, cyclic mechanical distension. Studies have shown that cyclic mechanical distension strengthens 
engineered vessels (Niklason et. al., 1999; Freed et. al., 2006; Isenberg et. al., 2006; Syedain et. al., 2008; 
Seliktar et. al., 2000; Huynh et. al., 2010) and promotes collagen production and cell alignment (Niklason 
et. al., 1999; Freed et. al., 2006; Isenberg et. al., 2003; Schutte et. al., 2010; Seliktar et. al., 2000). It also 
has enormous beneficial effects on SMC phenotype, ECM deposition, growth factor release, and 
vascular tone (Isenberg et. al., 2003). Biomechanical factors influence tissue growth (Isenberg et. al., 
2003; Niklason et. al., 1999; Syedain et. al., 2008), development (Guilak et. al., 1997; Niklason et. al., 
1999), maintenance (Butler et. al., 2009; Syedain et. al., 2008), degeneration (Butler et. al., 2009; 
Fujiwara et. al., 2003), and repair (Cheng et. al., 1997; Fujiwara et. al., 2003).  
16 | P a g e  
 
Cells receiving mechanical stimuli will align themselves in the direction of the stretch or flow to combat 
vessel weakness and increase cell length. Weakness could occur when cells are aligned in a random 
pattern within the wall of a vessel versus aligning along the direction of blood flow. Collagen and elastin 
fibrils will similarly align in a more compact manner in the direction of tension, increasing vessel 
strength and stiffness (Isenberg et. al., 2003; Tower et. al., 2002). TEBVs also respond to cyclic distension 
by producing more collagen and elastin, changing the composition of the extracellular matrix and 
further strengthening and stiffening vessel walls. Mechanical stretching has been shown to promote the 
expression of type I and III collagens, fibronectin, and tenascin-C in cultured ligament fibroblasts (Sahoo 
et. al., 2007). 
Mechanical properties can be engineered to match those of natural blood vessels. The burst pressure of 
a saphenous vein typically used in coronary artery bypass grafts in patients with heart disease is 1680 ± 
307 mmHg. (Konig et. al., 2009) A tissue engineered blood vessel cultured for 7 weeks with the same 
diameter and length as the tested saphenous vein had a burst pressure of 2594 ± 501 mmHg (Konig et. 
al., 2009). Vascular compliance (
  
  
; ΔV=change in volume, ΔP=change in pressure), stiffness (
 
 
; F=force 
applied, δ=displacement produced by force), tensile strength (calculated based on uniaxial tensile 
testing,  ultimate tensile stress, UTS, at failure), and burst pressure (  
      
 
; t=wall thickness (in), 
S=tensile strength of blood vessel (PSI), O=outer diameter (in)) can be altered and potentially controlled 
for based on the frequency and force used during conditioning.  
Compliance and stiffness are important properties contributing to overall TEBV health. Compliance 
refers to the ability of a blood vessel to recoil to its original shape after deformation by force. Stiffness is 
the blood vessels resistance to this deformation. Tensile strength is the maximum stress that a blood 
vessel can handle in a 2-D plane before failure. Burst pressure denotes the maximum stress that a blood 
vessel can handle in a 3-D plane before bursting during pressurization. Vascular stiffness correlates with 
increased cardiovascular risk (DeLoach et. al., 2008). By controlling these parameters, tissue engineered 
blood vessel properties can be catered to the needs of individual patients by altering the specific 
vascular type and size and decreasing susceptibility to cardiovascular disease. 
Increased ECM synthesis is a positive effect of biomechanical conditioning (Mauck et. al., 2000; Freed et. 
al., 2006; Buschmann et. al., 1995; Ku et. al., 2006; Niklason et. al., 1999; Seliktar et. al., 2000; Syedain 
et. al., 2009). Mauck (2000) studied dynamically loaded tissue engineered articular cartilage seeded on 
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agarose gels. Tissue disks were dynamically compressed at 10% strain at a frequency of 1 Hz; at a duty 
cycle of 1 hour on, 1 hour off per day for 5 days a week and 4 weeks total. Mauck (2000) found a sixfold 
increase in equilibrium aggregate modulus over controls and matrix elaboration due to heightened ECM 
synthesis over time for conditioned samples. 
Syedain (2009) created tissue engineered heart valves (TEHVs) by entrapping dermal fibroblasts into 
molded fibrin gels left to statically incubate for 2 weeks. These TEHVs were then strained incrementally 
at 5% (1st week), 10% (2nd week), and 15% (3rd week) over a 3 week period in a custom-built bioreactor 
at a frequency of 0.5 Hz. Syedain found that after cyclic stretching, collagen and cellular alignment was 
primarily circumferential, which correlates with native TEHVs. Collagen also appeared more organized 
into mature bundles at a density 86% greater than static TEHVs. Tensile strength and elastic modulus 
were also improved by over 97% and 77%, respectively, compared to static TEHVs.  
Mechanical properties of tissue engineered constructs (such as tensile strength, elastic modulus, and 
vessel stiffness) have been improved by mechanical conditioning (Hahn et. al., 2007; Diamantouros et. 
al., 2009; Freed et. al., 2006; Fujiwara et. al., 2003; Gimbronejr et. al., 1999; Isenberg et. al., 2006; 
Isenberg et. al., 2003; Konig et. al., 2009; Ku et. al., 2006; Niklason et. al., 1999; Schutte et. al., 2010). 
Hahn (2007) used mouse smooth muscle progenitor cells within poly(ethyleneglycol)-based hydrogels 
with adhesive ligands and a collagenase degradable sequence to create 3mm inner diameter tissue 
engineered vascular grafts. These grafts were subjected to 7 weeks of mechanical conditioning under 
pulsatile flow at 2 mL/sec. Results showed significantly higher collagen levels (resulting in higher tensile 
strength) and improved elastic moduli compared to static samples. 
Overall, TEBVs show much promise as alternatives to autografting for vascular replacements based on 
their burst strength, suturability, and mechanical similarities to native vessels. 
2. Drawbacks of Mechanical Conditioning 
Mechanical conditioning in culture is a difficult challenge. Systems have been developed which apply 
mechanical forces via piston/compression systems, substrate bending, hydrodynamic compression and 
fluid shear (Dobson et. al., 2006). Problems exist with these systems, namely, long term sterility and 
cells receiving adequate nutrients through the thickness of the vessel. In systems that use scaffolded 
tissue constructs, the scaffold takes on a portion of the mechanical load. Therefore, the tissue in culture 
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does not receive the full impact of the mechanical conditioning and as a result the production of ECM is 
hindered. (Dobson et. al., 2006) 
Studies have shown that excessive cyclic stretch is detrimental to cells (Fujiwara et. al., 2003; Gassman 
et. al., 2010). Fujiwara (2003) modeled this phenomenon using endothelial lung tissue. Lung tissue 
naturally stretches by an estimated 5% during normal breathing in vivo, but anything higher than 17-
22% may damage the endothelial cells of the lungs. The key is to condition cells at an “ordinary”, 
tolerable percentage that won’t over-stimulate or harm them (Fujiwara et. al., 2003). Despite these 
limitations, mechanical conditioning remains a widely used method to prepare tissue engineered 
constructs for the rigorous environment of the human body as it improves ECM synthesis, cellular 
alignment, and mechanical properties.  
2.1.3 Types and Studies Demonstrating Mechanical Conditioning Techniques 
Several different mechanical conditioning techniques have been shown to alter the mechanical and 
physiological characteristics of tissues. These techniques include magnetic stress, dynamic compressive 
loading, flow-mediated shear stress, continuous mechanical tension, stretching on membranes, and 
cyclic mechanical distension. Different tissue types require different mechanical stimuli to produce 
tissues with specific characteristics. For instance, mechanical conditioning that focuses on applied 
compressive forces would enhance a tissue’s compressive strength, while mechanical tension or 
stretching would improve elasticity and compliance. Cyclic mechanical distension is the type of 
conditioning the team chose to use for the purposes of our project. 
1. Cyclic Mechanical Distension 
A study conducted in 2000 by Seliktar cyclically strained collagen-gel blood vessel constructs composed 
of adult rat aortic SMCs mounted on etched silicone sleeves (coated in type I collagen and chitosan). The 
sleeves and constructs were sutured into in a sterile, air-tight bioreactor where media was added and 
0.2 µm filters served as vents for gas exchange. The tissue constructs were cycled within an incubator at 
a frequency of 1 Hz and 10% cyclic strain for 4 and 8 days. The silicone sleeve was distended using a 
regulated compressed air supply and a solenoid valve located outside the incubator.  
The vessels showed increased contraction and mechanical strength when compared to statically grown 
control constructs. The vessels conditioned for 8 days showed significant increases in ultimate tensile 
stress (the maximum load divided by the initial cross-sectional area of a sample) and material modulus 
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(stress divided by strain). Morphologically, the mechanically conditioned vessels showed higher 
circumferential orientation of the vessel cells. (Seliktar et. al., 2000) 
Another study focused on the effects of applied stretching on rabbit pulmonary arteries. They found 
that after four days of stretching, the amount of pro-collagen type I-positive cells grew, along with 
higher levels of protein synthesis within the smooth muscle cells (SMCs) and cell replication within the 
construct. (Kolpakov et. al., 1995) A similar study by Liu in 1998 used rat blood vessels. They discovered 
that continuous tensile strain on the vessels tested in 10 day increments over a period of 30 days 
resulted in better alignment of the SMCs. (Liu, 1998) 
Brett Isenberg and Robert Tranquillo (2003) studied the effects of long-term cyclic distension on 
collagen-based media equivalents (denatured, cross-linked type I collagen) consisting of adult rat aortic 
SMCs. The SMCs were grown and incubated on Teflon rod mandrels in standard cell culture medium, 
changed once per week. The tissue constructs themselves were 1-3 mm in length, 0.2-0.3 mm thick, and 
8 mm in inner diameter. The tissue constructs were conditioned on distensible latex mandrels inflated 
by pressurized air within an incubator 
The collagen-based media equivalents (MEs) were strained incrementally to the target percentage over 
3 days and remained at that frequency (0.5 Hz) and strain level (12.5%) for 5 weeks. The tissues were 
tested for various mechanical properties and collagen content. They found that mechanical conditioning 
for 2 weeks yielded little change in elastic modulus (E) or ultimate tensile strength (UTS), but 
conditioning for 5 weeks resulted in significant increases in both. Isenberg and Tranquillo found that cell 
age has no influence on response to stimulation and that 2.5% and 5% strain values are best for high 
UTS. They also found that a 10% strain value during mechanical conditioning is best for obtaining a high 
elastic modulus and higher elastin content within samples. This study failed to confirm whether or not 
an increase in cell number, collagen content, or fibril alignment was present in their tissue constructs as 
many other studies have claimed to have found. (Isenberg et. al., 2003) 
Niklason (1999) used pulsatile radial flow to cyclically distend silicone tubing loaded with PGA scaffolds 
seeded with neonatal SMCs at 2.75 Hz and 5% strain for 8 weeks. Niklason argued that pulsatile flow 
conditions (165 beats per minute and 5% radial distension) would more accurately represent conditions 
seen in vivo, and thus produce vessels better suited for eventual in vivo use. This study resulted in SMCs 
with an increase in modulus, collagen and elastin deposition, suture retention, and calponin and myosin 
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heavy chain (contractile components). Vessel wall thickness was also increased with longer culture time 
and pulsatile culture conditions. After treating the conditioned SMCs with prostaglandin F2α, the 
structure physically contracted as a natural blood vessel should. Table 1 summarizes the different 
characteristics measured in Niklason’s study. (Niklason et. al., 1999) 
Table 1. Characteristics of engineered vessels in Niklason's 1999 study. 
 
2. Other Types of Mechanical Conditioning 
Magnetic stress, dynamic compressive loading, flow-mediated shear stress, continuous mechanical 
tension, and stretching on membranes are all effective methods commonly used in the tissue 
engineering community to alter the physical and mechanical properties of tissue engineered constructs. 
Jon Dobson (2006) developed and prototyped a unique method to mechanically condition stem cells in 
vitro using biocompatible magnetic nanoparticles (MNPs) and ion channels present within the stem cells 
themselves. Dobson’s device applies stress to the cell membrane using forces applied directly to 
magnetic micro- and nanoparticles attached to the cell membrane via surface receptors. Quantitative 
results of this bioreactor system’s effects on tissue mechanical properties do not yet exist, but are 
currently being modeled in vitro. (Dobson et. al., 2006) 
Dynamic compressive loading is another effective means of conditioning cell constructs. Ballyns (2010) 
investigated the effects of dynamic compression loading on engineered bovine meniscal 
fibrochondrocytes seeded and crosslinked in alginate hydrogels and shaped as menisci. A custom 
bioreactor applied sinusoidal displacement in alternating one hour increments 3 times a week for 6 
weeks total. After 2 weeks, collagen content in conditioned samples increased 1.8 fold, compressive 
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modulus by 1.8-2.3 fold, and ECM content by 2-3.2 fold compared to static samples. (Ballyns et. al., 
2010) 
Flow-mediated shear stress is another method. In vitro models are limited in nutrient delivery due to a 
lack of blood supply. All nutrient/media delivery must occur through diffusion. Dynamic media flow 
within or around tissue-engineered constructs offer the best solution to enhance media delivery and 
waste exchange. They also simultaneously deliver flow-mediated shear stresses to cells seeded within 
the constructs, improving cell strength and structure (Butler et. al., 2009). Fluid shear stress at 
physiological (rest) conditions is estimated to be 1-50 dyn/cm2 in human arterial endothelial cells 
(Fujiwara et. al., 2003). 
A recent study has demonstrated that placing axons under continuous mechanical tension increases 
axon growth rates up to 1cm/day. This was accomplished by using a microstepper motor system to 
incrementally separate two neural membranes, allowing for spontaneous growth of axons from one 
membrane to another. This research is useful in the repair of nerve injuries using transplantable neurons 
with 10cm long axons for central nervous system repair. (Butler et. al., 2009; Pfister et. al., 2006; Smith 
et. al., 2001) 
Research was conducted concerning the effects of mechanical stretching on collagen synthesis by 
mesenchymal stem cells and aortic valve interstitial cells. Ku (2006) found that at 14% stretch there was 
a significant increase in collagen synthesis in both types of cells, directly affecting the rate of ECM 
production and valve strength. Collagen synthesis was dependent on the degree and duration of stretch 
in aortic valve tissue. (Ku et. al., 2006) In another study, rat vascular smooth muscle cells were subjected 
to cyclic strain induced by a vacuum below the culture plates the cells were grown on. Cyclic strain 
caused an increase in total cell count by 40% compared to control tests. (Wilson et. al., 1993) 
2.1.4 Conclusions 
The ultimate goal of blood vessel engineering is to create a nonthrombogenic, nonimmunogenic, 
suturable tissue that is able to withstand arterial pressures, is compliant, and can be remodeled in 
response to injury (Schutte et. al., 2010). Mechanical stimulation improves the overall structure and 
function of native and tissue engineered vasculature alike; this is imperative for achieving these goals. 
Biomechanical forces have been shown to enhance the physical characteristics of TEBVs. Mechanical 
cues cause change in cell morphology, physiology, biochemistry, and gene expression, all of which 
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contribute to overall tissue function in vivo. (Butler et. al., 2009; Diamantouros et. al., 2009; Freed et. al., 
2006; Isenberg et. al., 2003; Niklason et. al., 1999; Seliktar et. al., 2000; Syedain et. al., 2009) Cyclic 
mechanical distension of tissue engineered constructs has been shown to increase contraction and 
mechanical strength (Seliktar et. al., 2000; Isenberg et. al., 2003), increase circumferential cellular 
alignment along the vessel length (Seliktar et. al., 2000; Liu, 1998), and increase ECM synthesis and cell 
growth (Kolpakov et. al., 1995). 
Mechanical conditioning has become a major goal of recent tissue engineering efforts and has led to a 
shift in some of the primary bioreactor design goals. Bioreactors have evolved from acting solely as 
culturing devices to culturing while simultaneously conditioning tissue constructs. 
2.2 Bioreactors 
Bioreactors are biomimetic laboratory devices that regulate a number of environmental factors in order 
to create an optimal platform for biological activity. In tissue culturing and engineering, a regulated 
environment is crucial in order to promote cell growth and tissue structure and mechanics; bioreactors 
can be designed to control variables including pH, temperature, hydration, nutrition, and waste 
regulation and removal. Many of these conditions may be provided by an incubator. In the past decade, 
the focus of these bioreactors has expanded to include devices that induce mechanical stimulation, 
which improves compositional and mechanical properties. 
The following sections will profile several published bioreactor designs and experiments, which will help 
in identifying design intent, areas for improvement, and potential design opportunities.  
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2.2.1. Current bioreactor designs 
1. Seliktar’s cyclic strain bioreactor 
 
Figure 2. The Seliktar team’s final bioreactor design houses the tissue construct on a silicon tube as an external pneumatic 
control device imparts cyclic strain. Two filters installed into the device allow for gas exchange. (adapted from Seliktar et. al., 
2000.) 
Seliktar recognized the importance of mechanically conditioning TEBV constructs in order to improve 
their ECM production and mechanical properties. His team cultured adult rat aortic SMCs embedded in a 
collagen gel scaffold; once they were mechanically stable, the tissue constructs were transferred into a 
sterile bioreactor that interfaced with a controlled pneumatic flow loop to impart cyclic strain on the 
tissue samples. 
Seliktar’s design (Figure 2) consisted of a bioreactor chamber that contained an inlet and outlet port to 
allow for the mechanical flow. The team’s TEBVs were installed on a flexible silicone sleeve and fastened 
to the ports using sterile sutures. Gas exchange was made possible by two 0.2 µm filters that were 
installed into the top wall of the chamber. An external compressed air system connected to the 
bioreactor’s inlet and outlet ports using solenoid valves, and provided 5% and 10% cyclic strain to the 
inner silicon tubing. (Seliktar et. al., 2000) 
Seliktar’s design yielded TEBVs that exhibited improved cellular alignment and high collagen expression, 
but experienced large decreases in volume, length, and wall thickness. Still, despite the changes in size, 
the realignment of cells and collagen in response to mechanical conditioning yielded great increases in 
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mechanical integrity. Samples conditioned for only four days exhibited an 87% higher yield stress and 
eight day samples showed a 200% higher yield stress than static samples. (Seliktar et. al., 2000) 
2. Kelm improves production time using microtissues 
In 2009, Kelm sought to build a bioreactor system that would yield healthy, scaffoldless, small-diameter 
TEBVs while reducing the production time of previous designs. The team used myofibroblasts and 
endothelial cells to construct microtissues as an initial platform for the tissue culture. Kelm suggests that 
microtissues produce ECM quicker and more efficiently. This natural tendency to produce ECM, 
combined with pulsatile mechanical conditioning of the tissue, would reduce the required maturation 
time of the cells, and therefore expedite production of mature tissues. (Kelm et. al., 2010) 
 
Figure 3. A cross section of the tissue mount, the Falcon tube housing unit, and the path of media flow (adapted from Kelm 
et. al., 2010) 
Kelm’s bioreactor design consists of three main components: a pulsatile pump, a medium reservoir, and 
a structural unit. The pulsatile pump used is interfaced with control unit powered with a 1 bar inlet 
pressure; it uses cell media as a flow medium.  The two stated objectives of the novel assembly device 
are to grow the microtissues into a three-dimensional tubular shape and to enable circumferential 
mechanical stimulation. This assembly device is housed in a 50 mL falcon tube with a custom-made 
stainless steel cap. The assembly component is interfaced with the rest of the system through the steel 
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cap using silicon tubing (Figure 3). Finally, a nutrient medium reservoir is used as a junction between the 
assembly device and the pump to allow recirculation of the flow medium. 
Kelm’s design demonstrates that self-assembling microtissue constructs in conjunction with a pulsatile 
flow loop accelerates ECM production and tissue maturation, as the tissues showed very high collagen 
expression after only 14 days. This novel concept brings the industry one step closer to the quick and 
efficient production of autologous TEBV constructs. (Kelm et. al., 2010) 
3. Syedain enhances ECM composition 
Syedain’s team has developed a bioreactor that imparts cyclic mechanical strain on tissue engineered 
heart valves in an attempt to optimize compositional properties. Syedain’s design consists of a latex 
tube which houses the tissue engineered heart valves. The valves receive mechanical stimulation 
through a cell media flow via a syringe pump that has been custom-made for this system. A needle valve 
assists in redirecting the fluid back through the syringe. Media is also supplied to the latex chamber 
through a perfusion loop that is driven by a MasterFlex peristaltic pump. Using a second loop for media 
exchange allowed the mechanical frequencies and strains to be adjusted without completely altering the 
nutrition and oxygen supply to the tissue. (Syedain et. al., 2009) 
Syedain’s bioreactor yielded tissues that exhibited homogeneous cellularity, which proves that all of the 
cells were well-nourished and that the dual-flow loop system was successful. Furthermore, the 
conditioned heart valves expressed 86% more collagen than static control samples, but still fell short by 
37% in comparison to native heart valves. (Syedain et. al., 2009) 
4. Current device used in the Rolle lab 
The current technology used in the Rolle lab at WPI consists of a polystyrene BD Falcon conical tube 
(Figure 4 - A) as a tissue chamber and housing unit for a flexible silicone tube on which the vascular 
constructs are installed. The cap of the tube has been modified in order to contain a threaded barb, 
which acts as a platform for the junction between the compressed air chamber (which provides the 
mechanical loading) and the bioreactor cartridge. The cap system is also fixed with a heat sleeve and 
anti-leak o-rings in order to ensure the security of the cartridge. Furthermore, an air pressure fitting has 
been installed into the cap. The final piece of the cap system is a sterile air filter that allows for gas 
exchange as the tissues are being cultured and conditioned. The bottom of the silicone tubing contains a 
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needle end cap, onto which a small weight is secured. This grounds the tubing and, consequently, the 
TEBVs, and helps control the mechanical distension of the system. (Ali et. al., 2009)  
One unique feature of the air pressurization design in comparison with the other profiled current 
technologies is the high throughput that it allows. (Figure 4 – B) The air pressurization design uses a 
manifold to distribute the bursts of compressed air among up to eight bioreactor cartridges. This design 
allows for several isolated tissue cultures to be active and conditioned simultaneously. (Ali et. al., 2009) 
2.2.2. Areas for improvement and design opportunities 
Several different bioreactor designs, both in the general industry and in the microcosm of the Rolle lab, 
have exhibited the potential of enhancing ECM production and structural integrity of TEBVs through 
mechanical conditioning.  It is imperative to address the shortcomings of each design in order to 
optimize the biological performance and economical and industrial efficiencies of these devices.  
These issues were partially addressed by Kelm (2010), and they were able to reduce the total production 
time for a matured vessel, the design still retained a very low throughput for the amount of work that 
was required to yield a desirable tissue product. The only profiled bioreactor that exhibits the capability 
to yield a high throughput is the air pressurization design that is currently being used in the Rolle lab at 
WPI. Even so, the current device has sacrificed sterility (threads warp in the autoclave). It is not designed 
for efficient and constant media exchange, and does not have the customizable features that are 
Figure 4. The Ali design uses tube as a tissue chamber, and allows up to eight isolated bioreactor systems to operate at one 
time. (Ali et. al., 2009) 
A B 
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needed for future studies (interchangeable with a growth chamber; ability to use different tube 
diameters, etc.). 
The MQP team seeks to alleviate these complications by developing and prototyping a design that 
allows for high throughput of isolated tissue cultures while maintaining the chemical, biological, and 
mechanical conditions that optimize cell growth and alignment, and ECM production comparable to 
native tissue. 
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Chapter 3 – Project Strategy 
 
Our initial client statement challenged us to design a device that overcomes limitations associated with 
current bioreactors that mechanically condition tissue engineered vascular constructs. It was then our 
responsibility to conduct an in-depth literature review in order to gain a full understanding of the 
current technology. As we developed an understanding of the problem, we began compiling a list of 
objectives and constraints. Utilizing a collection of client interview data, we then applied these 
objectives and constraints and created a list of functions and means for our device, outlined in Chapter 
4. These means were then analyzed and several design alternatives were created. The designs were 
further scrutinized and with continued research we decided on and refined a final design, which we 
evaluated through a series of quantitative and qualitative bench top tests. 
3.1 Initial Client Statement 
The initial statement provided by our project advisor, Marsha Rolle, was: “Bioreactors have been shown 
to improve the structure and function of engineered tissues by providing conditions that simulate the in 
vivo environment in which the tissue normally exists.  In addition, bioreactors can facilitate seeding, 
organization and culture of cells to support tissue growth and maturation.  For tissue engineered blood 
vessels, bioreactors that provide cyclic, circumferential mechanical loading have been shown to increase 
cellular alignment and increase extracellular matrix (ECM) synthesis, leading to improved tissue 
mechanical strength.  The goal of this project is to create a cartridge to house a tissue engineered blood 
vessel that interfaces with a pressurization system that imparts cyclic circumferential strain on the tissue 
during culture.  The cartridge should include an external medium flow loop to provide continuous 
nutrient supply to the tissue.  Ideally, the cartridge should be inexpensive and easy to manufacture, such 
that multiple cartridges can be used in a single experiment to culture batches of tissue engineered blood 
vessels.  Finally, the cartridge should be interchangeable with the luminal flow cartridge under 
development by another MQP team and members of the Rolle Laboratory.” 
3.2 Objectives 
Based upon our initial research of past MQPs and published literature, we developed the following 
objectives: 
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 Accurate: Must produce a strain magnitude within 10% ± 1%  
 High Throughput: The ability to “condition many rings or tubes simultaneously, run 
multiple media conditions simultaneously, and/or vary culture duration.” (Ali et al., 
2009) 
 Adjustable: Able to condition TEBVs of different diameters and lengths at different 
frequency and strain levels. 
 Easily Secured: TEBVs should be easily secured prior to testing. 
 Easily Removed: TEBVs should be easily removed after testing. 
 Inexpensive: Both to build (using cheap materials/parts) and to maintain (using less 
media, durable and reusable materials, energy efficient, less time expense). 
 Easy to Use: With minimal manual input, using fewer, simpler steps. 
With the completion of the literature review, the team then developed a Pairwise Comparison Chart 
(PCC) which helped us determine which objectives needed to take priority when we reached the 
conceptual design stage (Chapter 4). In total, nine objectives were analyzed in order to establish a set of 
design priorities. Additionally, the PCCs were issued to our advisor and a graduate student, who as 
actual clients of the device could further validate the design priorities. Our PCC can be found in 
Appendix A – Pairwise Comparison Chart (PCC).  
As seen in Table 2, three areas were determined to be a priority for both clients and the team: accuracy, 
media supply and waste removal. Accuracy was defined as our device’s ability to induce 10 ± 1% cyclic 
strain. As found in literature, strains of this magnitude significantly increased the mechanical and 
structural integrity of TEBV samples. (Seliktar et. al., 2000) Both media supply and waste removal were 
related to our device’s ability to sustain cell constructs. It was considered a necessity to maintain an 
ample supply of nutrients for the cell samples during conditioning. We all agreed that our design must 
provide constant nutrient supply and allow for repeated replenishment of nutrients. Additionally, all 
users felt that waste removal was equally important as to maintain cellular homeostasis. These areas of 
interest are highlighted yellow in Table 2. Highlighted red in Table 2 is an additional area of interest and 
refers to the amount of effort required to secure tissue samples to our device.  As a team we did not feel 
this was as important as some of the other objectives, however after receiving the client completed PCC, 
we realized that it may be more important than initially thought. Newly cultured tissue samples are very 
fragile and during the process of transferring the samples from their culture molds to our device they 
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can easily break. Both clients decided that our device should facilitate this process. This list of priorities 
and weighted objectives functioned as the backbone for the development of design alternatives.  
Table 2. Client and Team PCC Comparison 
Objective Rolle Gwyther Team Average 
Media Supply 8 7 7 7.333333 
Waste Removal 7 5 6 6 
Accurate 4 8 6 6 
Easily Secured 6 5 3 4.666667 
High 
Throughput 2.5 4 4 3.5 
Easily Removed 5 2 3 3.333333 
Programmable 0.5 1 5 2.166667 
Adjustable 0.5 4 1 1.833333 
Inexpensive 2.5 0 0 0.833333 
 
3.3 Constraints 
In addition to the development of objectives, we also needed to determine our design constraints. Our 
two most limiting constraints were time and budget. The final deadline for project completion was April 
21st, 2011 on Project Presentation Day. Our budget consisted of $368.00, which would have to cover all 
of our purchased materials for prototype and final design manufacturing. Safety was another priority for 
all of our alternative designs. The design could not harm the user or cells in any way. The bioreactor 
must be biocompatible, non-toxic to the cells within it, and contain no possible outlets for injury. 
The materials we use in our design must be sterilizable in order to avoid contaminating tissue samples. 
In addition to sterility, cell viability must be maintained by means of constant media supply to the TEBVs 
during mechanical conditioning. Waste regulation must also be accounted for in order to guarantee 
optimal cellular conditions. 
After discussion with our client, we determined that the bioreactor must be transparent to allow for 
imaging and observation during TEBV testing. Transparency aids in the detection of experimental failure, 
such as: ring failure, culture contamination, or component failure. 
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Since our device doesn’t have a means to self-regulate physiological conditions, such as temperature 
and humidity, the device must fit within an incubator. Each shelf in the incubator in our laboratory is 40 
cm wide x 15 cm high x 40 cm deep. This constraint impacted our designs by limiting the available space 
that our device can occupy. 
3.4 Revised Client Statement 
After an improved understanding of the assigned problem, and an extensive knowledge of the current 
technology, we were able to apply our metrics and overall project strategy, and improve upon our initial 
client statement. The resulting client statement reads as follows: 
 
To design a bioreactor used in conjunction with a pressurization system that 
distends the inner diameter (2mm) of tissue engineered blood vessel rings and/or 
tubes (1cm long) by 10% (± 1%) at a frequency of 1 Hz. This will be accomplished by 
means of cyclic circumferential strain, which increases cellular alignment and ECM 
synthesis. Multiple cartridges should allow for media regulation in a safe, sterile, 
leak-proof in vitro setting that accurately simulates an in vivo environment. Finally, 
the device should be inexpensive and easy to manufacture and use. 
 
With this enhanced definition of the problem we then entered the development stage which is 
completely outlined in the next chapter.
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Chapter 4 – Alternative Designs 
Based on our initial client statement, we developed constraints, objectives, functions, and means by 
which to formulate design alternatives. Using the air pressurization system designed by Ali, 2009 (Figure 
5) as a template and the designs of other successful bioreactors as models, the team evaluated a 
number of design alternatives. 
 
 
Figure 5. Air pressurization system (Ali et. al., 2009) 
After studying the Ali tissue chamber design outlined in yellow in Figure 5, we determined that the 
design had several faults. The silicone tube fixed to the threaded cap was dangling within the BD Falcon 
conical tube (Figure 4 - A). Without any effective means of fixing the free end of the silicone tube, there 
was nothing to prevent it from curling or knocking against the sides of the conical tube. The only means 
of holding the silicone tube taut was via an end weight attached to the needle endcap which was glued 
into the free end of the silicone tube. This endcap was still not effective at preventing the free swinging 
of the silicone tube during transport. The vertical orientation of the tissue chamber makes the tissue 
rings susceptible to gravitational forces that can merge multiple rings together or possibly even slide 
them off of the silicone tube entirely. A horizontal orientation would eliminate this problem.  
Other drawbacks of the pressurization system include its size and user-friendliness. The pressurization 
system makes use of compressed air, which is stored in large tanks in the lab. This takes up lots of space 
in the lab and is loud and disruptive in the user’s workspace. Furthermore, a heavy aluminum base 
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makes the device awkward to transport. Finally, the device was designed so large that it cannot fit in a 
laboratory incubator and therefore cannot be used for culture experiments. Given these limitations of 
the initial design, we chose to pursue a completely novel approach to our project. 
During design conception, we made an effort to use common parts (standard sized screws, syringes, 
tubes, motors, etc.) to reduce costs of manufacturing and materials, expedite the design process, and to 
minimize production times. 
4.1 Functions (Specifications) 
With a firm understanding of our objectives and constraints we then began defining potential functions 
and means which could be applied to design alternatives. We decided to separate the design functions 
into two categories: functions/means for the tissue chamber and functions/means for the mechanical 
conditioning system. Below is an itemized list of our proposed design functions. 
 
Tissue Chamber Functions 
 Provide nutrients to cells 
 Remove cell waste 
 Allow access to and removal of tissue rings/tubes 
 Allow gas exchange 
 Compatible with a pump 
Mechanical Stimulation System Functions  
 Cyclically distend tissue samples by 10% 
 Run during the duration of mechanical conditioning of samples 
 Consistent (must strain at 10 ± 1% per cycle) 
 Adjustable pressure controls (per tissue chamber) 
 Compatible with tissue chamber 
In order to visualize these functions, after making a list, we then created a Morphological Chart (Table 3) 
and continued to expand upon the potential means for each function. 
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Table 3. Morphological Chart 
Functions Mean 1 Mean 2 Mean 3 Mean 4 
Tissue Chamber         
Media Provision 
Submerge in 
Media Rotisserie Media Pool Porous Mandrel    
Cell Waste Removal Aspirator Drainage Flow Loop Filtered Reservoir   
Tissue Sample Access Removable Lid 
Individual Tissue 
Chambers Open Container   
Gas Exchange HEPA Filter Expose to Air Petri lid   
Humidity Regulation 
Exposure to 
Incubator       
Pump Compatibility Syringe Pump Peristaltic Pump 
Mechanical (CAM/Motor) 
Pump 
Air Pressurization 
System 
          
Mechanical Conditioning 
System         
Cyclic/Circumferential 
Loading Syringe Pump Peristaltic Pump 
Mechanical (CAM/Motor) 
Pump 
Air Pressurization 
System 
Consistent Work Output Programmable Leak Proof Mechanically Adjustable Spring 
Adjustable Pressure Programmable TRIM Pot 
Bread Board w/ Variable 
Resistors 
Motor w/ Turn Off 
Switches 
Tissue Chamber 
Compatibility 
Fluid Two-Way 
Valve 
Quick Connect Tubing 
Couplings     
 
4.2 Conceptual Designs 
In order to meet our outlined objectives, we broke up our bioreactor system into two major 
components: a mechanical conditioning system and a tissue culture device. Each had their own set of 
objectives and functional requirements. 
4.2.1. Mechanical conditioning system 
The purpose of the mechanical conditioning system is to use a flow medium to distend an elastic tube 
on which engineered tissue samples are mounted. Distensible tubing has been used in past research as a 
means of imparting mechanical strain on tissue engineered constructs (Niklason et. al., 1999). The 
elastic tube is generally seeded with tissue constructs and inflated by air or liquid to distend the tube, 
and thus the tissues mounted on the tube. 
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1. Peristaltic pump 
Using the Syedain heart valve bioreactor design 
(Syedain et. al., 2009) as a model, the team 
considered the use of a peristaltic pump as a 
means to provide circumferential mechanical 
stimulation to the TEBVs. The pump operates by 
using a rotating cam (Figure 6 - 1) to flex plastic 
tubing (2) that is fixed to a frame (3). The design 
would incorporate inlet and outlet channels (4, 5) 
in order to allow for a continuous circuit of 
flow medium. 
Using a peristaltic pump as a design component is very appealing, as it is an existing technology and is 
programmable. However, one major drawback is that existing models do not offer high throughput 
capabilities. 
2. OctoPump 
The next design alternative was conceived by 
reverse-engineering a syringe pump. The 
design consists of eight syringes (Figure 7 - 1) 
housed in a circular frame (2). The pump uses 
an offset rotating cam (3) located in the 
center of the frame to depress the plungers 
of the syringes. The displacement of a 
medium would inflate a plastic tube on 
which the tissue rings are housed, thereby providing the desired distension. 
This novel design allows for high throughput of isolated samples, and the cam device could be 
manipulated to adjust flow frequencies and volumes. However, in order to remove a single sample the 
user would have to deactivate the entire system.  
 
 
 Figure 6. Peristaltic pump 
Figure 7. OctoPump 
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3. Wheel and arm motor 
Another design that mimics a syringe pump is the wheel 
and arm motor assembly. A small mechanical motor 
(Figure 8 - 1) spins a machine wheel (2) attached to a 
flat arm (3). The flat arm’s far end is attached to a 
housing device that is fixed to several syringe heads (4). 
As the wheel spins, there is a horizontal translation in 
the syringe heads, causing them to depress and retract. 
The flat arm can be fixed to the wheel at any of several 
points (5), resulting in different radii and therefore 
different flow volumes.  
This design concept is appealing as it combines several simple existing technologies for a novel 
application. It also serves as an effective, high-throughput alternative to the syringe pump, which was 
deemed out of the team’s price range. Some predicted complications include size and isolating single 
syringes or assembly systems. 
4. Solenoid flexion device 
The next preliminary design was a solenoid flexion 
device. The design consists of a battery-operated 
solenoid (Figure 9 - 1) suspended above the plastic 
tubing (2) which contains the tissue samples. Fixed to 
the solenoid is a rubber press (3). The size of press 
would be chosen depending on the volume of water in 
the tubing that needed to be displaced in order to 
inflate the tubing and achieve the desired 10% 
distension of the tubing and TEBVs.  
While this design assembly eliminates several parts and 
fixture points – and in turn, eliminates opportunities for the 
device to fail – it was deemed unfit for this project. It was discovered that it is very difficult to program a 
solenoid to function at speeds as low as 60 RPM, which is required for the mechanical conditioning to 
 
Figure 9. Solenoid flexion device 
Figure 8. Wheel and arm motor 
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take place at 1 Hz. Furthermore, the movements of the solenoid are abrupt, irregular, and may be 
abrasive to the silicone tubing. (J. O’Rourke, personal communication, October 2010) 
5. Motor and cam system 
The team’s final 
conceptual design for the 
mechanical conditioning 
system involves a small 
motor (Figure 10 - 1) that 
contains a cam and cam 
collar (2). As the cam 
spins, it remains tangent 
with the head of a syringe 
plunger (3) that displaces 
a flow medium from a 1 
mL syringe (4) through a series of luer fittings (5) and into a flexible plastic tube (6) that houses the 
tissue rings. The tube is secured at the distal end using a pinch clamp (7). The plunger is fitted with a 
compression spring (8) that makes it to retract, stay in contact with the cam, and allows for cyclic 
pumping of the syringe. 
One highlight of this design is that the user may choose different cams or motors to customize the 
parameters of the mechanical conditioning. For example, a larger cam would displace a larger volume of 
medium through the syringe, thereby causing a greater distension of the tissue rings. A motor may be 
run at lower or higher voltages to increase or decrease the frequency of the conditioning. 
4.2.2. Tissue chamber 
All of the designs for the mechanical conditioning system involve the tissue samples being mounted on a 
flexible plastic tube that is inflated in order to achieve the desired distension. The final assembly 
therefore requires a unit made from biocompatible materials that safely houses the tubing and cells, 
prevents contamination, allows gas exchange between the cells and the environment, and interfaces 
effectively with the mechanical conditioning system. 
Figure 10. Motor and cam system 
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The current design used in the Rolle lab in conjunction with the air 
pressurization system contains a number of flaws. The design fails 
to secure the silicone tubing at both ends. Fixing the silicone tube 
at both ends and keeping it taut prevents the tube from moving 
and ensures that the displacement of water through the tube leads 
to inflation and distension. Additionally, the current design offers 
no outlets or means for waste removal and media exchange.  
1. Double threaded cartridge 
The first design alternative was based on the tissue chamber from 
the air pressurization design, which uses a series of polystyrene 
Falcon conical tubes. Because these units are small and create 
isolated environments for each tube and set of cells, there are 
many possibilities for a high throughput assembly. The design 
consists of a hollow tube (Figure 11 - 1) with threaded caps on each end (2). One cap would 
permanently house the distal end the silicone tube (3). The second cap would function much like the 
current design, as it would be interfaced with a fitting that leads to the pump system (4). A lock-and-key 
pin mechanism (5) fixes the proximal end of the silicone tube to this cap.  Because the tubing is fixed to 
the threaded caps before they are both screwed 
onto the Falcon tube, the tubing is subjected to 
torsion and possible tearing or deformation. 
Therefore, the biggest challenge associated with 
this design would be to not compromise the safety 
of the silicone tube and the tissue sample when 
fastening the threads. 
 
2. Removable compartments  
This design uses an original assembly of isolated, removable plastic compartments (Figure 12 - 1) that fit 
into a containment unit (2). The frame separates the compartments, acts as a junction between the 
pump system and cartridges, and provides hinged covers for each compartment (3). The hinged covers 
 Figure 11. Double threaded cartridge 
Figure 12. Removable compartment assembly 
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loosely sit atop the compartments, which allows for gas exchange and 
provides easy access to the interior for aspirating and changing out cell 
media. Finally, the fronts of the compartments will contain a small 
opening (4) above the media pool to which the silicon tubing will be fixed 
by a clamp located outside the tissue chamber.  
3. Milled tissue chambers  
This conceptual design consists of milled plastic tissue chambers (Figure 
13 - 1) which interface with a mechanical conditioning system’s syringe (2) 
through a series of luer fittings (3). The flexible plastic tubing is attached 
to the luer fittings using heat shrink-wrap tubing (4). The distal end of the 
silicone tubing is clamped using a pinch clamp (5) that is fixed to the 
bottom of the chamber using a stainless steel dowel. 
4.2.3. Design assembly 
1. Wheel and arm assembly 
The design is driven by the wheel and arm motor (Figure 14 - 1) as 
described in Section 4.2.1.-3. The flat arm is interfaced with a fixture that holds the heads of several BD 
10cc syringe plunger heads (2). Displaced flow medium is transferred from the syringes into the tissue-
mounted silicone tubing located in the compartments of the removable compartment assembly (3), 
which will be constructed as described in Section 4.2.2.-2. The combination of these design alternatives 
allows for high throughput, isolated systems for the simultaneous operation of independent 
experiments, and high customizability.  
One problem that arises with this design is that a single compartment cannot be removed without 
shutting off the pump for the other compartments. Also, even if a single compartment can be removed, 
there is nothing stopping the water in the silicone tubing from spilling out. The team conceptualized a 
system that may overcome these design barriers. Each syringe would pass the flow through a three-way 
cross flow valve (4). The top end of the valve will lead into a BD Falcon polypropylene tube, which would 
be fixed with a loaded silicone tube (5). When a tissue chamber needs to be removed, the flow can be 
redirected using the cross flow valve into the Falcon tube, which serves as a temporary reservoir for the 
Figure 13. Milled tissue 
chamber 
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flow medium. When the tissue 
chamber is put back into the 
system, the flow can be directed 
again back into the chamber. 
When the user wants to remove 
a single compartment, he or she 
will simply redirect the flow to 
the reservoir, stopping the flow 
into that cartridge without 
interrupting the others.  This still 
leaves the problem of water 
leaking from the system into the 
incubator following removal of 
the compartment. The remaining 
end of the three-way valve will 
be fitted with a quick-coupling 
fixture that only allows one-way flow. 
 
2. Pyramid assembly 
The team conceptualized 
modifications to the wheel and 
arm design. In order to increase 
user control over each TEBV 
sample, the team sought to 
create isolated systems for each 
tissue chamber. In order to 
achieve this, the team 
concluded to use small gear-box 
hobby motors (Figure 15 - 1). 
Figure 14. Wheel and arm assembly 
Figure 15. Motorized pyramid assembly and pinch clamp (ZManCorp.com) 
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These motors can be purchased off the shelf and run at 60 RPM. Again, a machine wheel (2) and flat arm 
(3) would be fixed to each motor. The opposite end of the flat arm would attach to the plunger of a 1-mL 
syringe (4). As the motors rotate the wheel, the flat arms would undergo a horizontal translation, 
causing the plungers to depress and retract. These syringes interface with milled tissue chambers (see 
Figure 13) which contain an internalized pinch clamp (5). The motors are arranged in a staggered 
‘pyramid’ formation in order to minimize the amount of occupied space while maintaining the linearity 
of the system and allowing the user to easily access the tissue chambers. To accomplish this, three 
different sized flat arms are required (6). 
In order to improve manufacturability, the team dismissed the flat arm component of the design en 
route to developing the following design alternative: 
2. Motor-cam series 
The motor-cam series builds on the 
concept of the pyramid assembly, but 
simplifies it by reducing the number of 
parts and fittings, improving 
manufacturability, and internalizing the 
mechanism in order to make a compact, 
customizable, user-friendly device. The 
assembly consists of a plastic base (Figure 
16 - 1) which houses six 60 RPM gear-box 
motors (2). Each motor is fixed with a 
cam (3) which rotates and cyclically depresses the plunger of a 1-mL syringe (4). Again, the design 
employs tissue chambers and pinch clamps as seen in Figure 13. Six of these tissue chambers (5) are 
housed in a removable UHMWPE tray (6) that fits into the base.  
4.3 Comparison of Design Components 
In addition to comparing alternative designs as a whole, we compared individual components used 
within these designs to aid in our selection of pieces for a final working assembly. We compared these 
components using research, interviews with experts and clients, experimental testing, and general 
knowledge obtained during the course of our project. 
Figure 16 Motor-cam series 
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1. Distensible tubing 
We were given fifty feet of clean, not sterile, 1.4732 mm inner diameter x 1.9558 mm outer diameter 
silicone tubing from Specialty Manufacturing Inc. (SMI) at the start of our project. We decided to build 
our design around this source of distensible tubing due to the Rolle Lab’s experience handling this 
particular size and brand. 
Silicone tubing has been shown to be an effective means of distending tissue engineered constructs 
(Niklason et. al., 1999). The inner diameter of the tissue rings being used in our project (2 mm) match 
almost precisely with the outer diameter of the silicone tubing (1.9558 mm), leaving an extra 0.04 mm 
to aid during tissue ring loading. Loading involves delicately placing a tissue ring or tube around the 
outer circumference of a sterile distensible tube. The tube is then inflated or pressurized continuously at 
10 ± 1% of its outer diameter at a frequency of 1 Hz over a 3-7 day period (in our studies). In the event 
that the tissue rings adhere to the surface of the silicone tubing during distension, they can be detached 
simply by stretching on either end of the silicone tube (M. Rolle, personal communication, September, 
2010). 
Silicone tubing is autoclavable, inexpensive (at ~2 cents per 10 cm length), disposable, can interface with 
syringe tips, and will not leach when soaked in cellular media for long periods of time. 
2. Mechanical conditioning device 
We considered three different device designs before reaching a final decision for a means of distending 
the silicone tubing. First, an air pressurization system designed by the Ali MQP in 2009 was considered 
as a means of distending silicone tubing via air flow. This device used a pressure control system which 
provided a constant high pressure of 26 psi which obtained the 10% strain on the silicone tubing. A 
three-way solenoid valve controlled by an electrical timer switched back and forth between the system’s 
high (26 psi) and low (4 psi) pressure inputs at a frequency of 1 Hz. The use of air pressurization proved 
to have its drawbacks with the Ali MQP’s system. The entire system was large and complicated, 
involving numerous connections between the air compressor, pressure control devices, distribution 
manifold, and tissue chambers. The pressurization system shown in Figure 5 consists of every part of the 
system except for the tissue chambers outlined in yellow. The overall size of this system makes it 
incredibly difficult to run within an incubator, as well as incredibly noisy. While there is an option for 
running tubing outside of the incubator, the size of the distributor (labeled as 1 in Figure 5) and bulk of 
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the remainder of the system would make it difficult to arrange within and around an incubator. The 
greater the number of connections between the system and the tissue chambers, the greater the 
chance of leaks, loose fittings, and difficulty in monitoring air flow and air levels. (Ali et. al., 2009) 
Our second option was to use a solenoid coil actuator to displace a specific volume of water within a 
silicone tube to achieve 10±1% distension. Solenoids work by creating a magnetic field around a 
solenoid coil which moves a metal armature positioned in the middle of the circular coil. The armature is 
forced down by a spring, pushing the stem and base onto a silicone tube filled with water positioned 
beneath the solenoid. The entire system is pictured in Figure 17. The magnetic field can be controlled to 
push the armature at a rate of 1 Hz based on the number of 
loops in the solenoid coil. There are several problems 
associated with this system, namely that solenoids operate 
in a very abrupt manner (J. O’Rourke, personal 
communication, October 2010). The movement of the 
armature and flexion of the spring are not smooth in 
motion, which could cause damage to the silicone tube and 
friction in the system. Using a solenoid in a moist, humid 
environment may disrupt solenoid function as well. The 
affects of electromagnetic fields on TEBV growth is also 
unknown and could potentially be problematic. 
Our final option is a motor, pictured in Figure 18. Motors can effectively push syringe plungers when 
attached to a cam and/or flatbar assembly. One motor could be used to move multiple syringes at once, 
or multiple motors can be used to move syringe plungers individually. The movement of these plungers 
at 60 RPM results in distension of the silicone tubes at a frequency of 1 Hz. When preloaded with water 
or media, the silicone tubes can be distended by 10±1% depending on the length of the flatbar or 
dimensions of the cam. 
Figure 17. Solenoid actuator (Edited from 
tpub.com) 
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Figure 18. 12V DC 60 RPM high torque gear box electric motor 
We chose to use the motor as our method of mechanically distending the silicone tube due to its low 
cost (see Appendix F for pricing), adjustability of frequency, smooth and quiet operation, size (37 mm in 
diameter, 70 mm in height), and simplicity over the other two design alternatives. Using multiple motors 
further improves the design by allowing for variation of separate tissue chamber conditions during 
experimentation. By using multiple motors, individual chambers can be shut off or set to run at a slower 
speed with the flip of a switch or the turn of a knob. We found during bench-top testing that our motor 
(Error! Reference source not found.) ran very quietly and without complications for 7 days on its own. 
otors can be positioned in a variety of different ways to achieve the same function, allowing for more 
design flexibility. 
3. Tissue chamber 
We narrowed our design options down immediately when deciding between using tissue chambers 
where the cells would be seeded on a vertical silicone tube (such as in the Ali 2009 MQP) versus being 
seeded horizontally. We eliminated a vertical tissue chamber design based on our assessment of the air 
pressurization system used in the Ali (2009) MQP introduced in the beginning of this chapter. Our final 
concern with the vertical tissue chamber design of the Ali MQP is the amount of wasted cell media used 
in the 50 mL conical tubes (~35 mL of media used if filled as shown in Figure 4). A horizontal design in 
which enough media would be used to submerge the tissue rings would reduce the costs related to cell 
media usage.  
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The only stated concern of the Ali MQP team regarding horizontal tissue chamber arrangements is “the 
chance that flexible tubes will not remain completely horizontal when inserted into the media” (Ali et. 
al, 2009). We saw a way to overcome this problem, and so we chose to pursue horizontal tissue 
chamber arrangements. Our only foreseeable challenge with horizontal chambers was in finding a way 
to submerge distensible tubing (loaded with tissue rings) within the media in the chambers without 
leaking. All chamber designs must allow for tissue ring submersion and interface with the motor-cam 
mechanical conditioning device. We considered two different design variations for a horizontal tissue 
chamber based on our decisions to eliminate vertical designs and use motors as a mechanical 
conditioning device. 
The first tissue chamber design involved using a solid block with separate chambers milled out of it, and 
the second involved having separate removable chambers housed on a removable tray (Figure 19). Both 
designs are relatively easy to manufacture through milling and sawing and both have removable 
components. The tissue chamber with separate, removable chambers was deemed to be a better option 
for our design. By having separate chambers, the user could have the option of removing a single 
chamber from the system in the event of sample contamination 
or a problem with the mechanical components. In the event 
that a chamber is damaged in some way, it can simply be 
replaced, eliminating unused or contaminated space in the 
system. Both tissue chamber designs would interface with the 
motor-cam mechanical conditioning device through a hole in 
one of its walls. An air and water-tight seal would allow for the 
silicone tubing to pass into the tissue chamber for submersion, 
while maintaining a sterile environment within the tissue 
chamber itself. 
One function of the tissue chambers is to allow for the changing and replacing of media. Both the single 
unit and individual chambers function similar to culture dishes, in which media must be manually 
aspirated and added to feed the cells contained within them. The chambers would be complete with 
loose fitting lids, which act as culture dish lids in permitting gas exchange and offering protection from 
potential airborne contamination in non-sterile settings. Both the single unit and individual chambers 
would facilitate media change quite easily with these design considerations. The single unit acts as a tray 
Figure 19. Individual removable chambers 
on a removable tray 
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in itself while the individual compartments are housed on a removable tray, allowing for all chambers to 
be moved at once for both designs. 
We chose to use the individual, removable chambers on a removable tray to do its greater flexibility for 
a variety of situations that could occur in the laboratory during testing. 
4. Mechanical attachment to motor 
We considered two different options for a means of mechanically pushing the syringe plunger using a 
motor. The first conceptual design used a cam and flat arm design. We would manufacture a cam of 
appropriate dimensions and attach and clamp it to the shaft of the motor via a D-shaped hole at the 
center of the cam. In order to achieve 10% distension, the syringe plunger would have to be moved by a 
certain distance depending on the size of the syringe and the volume of fluid needed to distend the 
silicone tubing. The distance that the plunger must be moved is equal to the distance between the 
center of the D-shaped hole and the center of the hole drilled to connect the flat arm to the cam. The 
other end of the flat arm connects to a syringe plunger, the movement of which controls the distension 
of a silicone tube and the tissue rings encircling it. Cams and flat arms can be manufactured relatively 
easily to whatever specifications are desired. Flat arms can be as long as necessary to accommodate for 
individual motor spacing, although the longer the flat arm, the larger the overall device. The cam and 
flat arm design can be seen in Figure 20. 
 
Figure 20. Top view of cam and flat arm design (left) and side view of cam design (right) for motor-syringe attachment 
Our second conceptual design was based on using just the cam without a flat arm. The cam dimensions 
would be calculated in the same way as for the cam and flat arm design. The cam would rotate, 
depressing the plunger of the syringe with its longer side. A compression spring controls the plunger’s 
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extension as the cam rotates to its shorter side. Springs will be necessary to ensure that the syringe 
plunger maintains contact with the cam and that the plunger fully extends back to its original position 
within the one second time frame required for running at a frequency of 1 Hz. The spring must be big 
enough to fit around the plunger, yet not exceed the size of the plunger head in order to remain 
positioned correctly between the syringe barrel and plunger during conditioning. By switching out the 
cam for a different sized one, the volume of water displaced by the syringe can be catered to the user’s 
needs. The elimination of the flat arm in this design allowed for us to shorten our design considerably. In 
theory, the cam design is more compact, it allows for the motor to be inverted and anchored into the 
base of the device to further save space. The use of less material for the base of the device saves 
material costs, and the odds of mechanical failure are reduced by limiting the number of mechanical 
connections in the overall system. 
5. Syringe tips 
We considered three different syringe tips as a means of connecting our syringe to the 1.9558 mm inner 
diameter silicone tubing. 
Blunt end metal syringe tips (2 mm diameter; Figure 21, right) were first considered due to their 
similarities in diameter to the silicone tubing we were using. These tips effectively interface with a large 
variety of syringes, including the 1mL luer-slip and luer-lock. 
 
Figure 21. Pictured left to right, 1/16" inner diameter female barbed luer-lock tip, 1/16" inner diameter male barbed bayonet 
tip, and 2mm blunt end metal syringe tip. 
Problems arose with this type of syringe tip when trying to build it into the wall of the tissue chamber. 
Any tip would have to be sealed into the wall of the tissue chamber to allow for silicone tube 
submersion and easy connection from the sterile tissue chamber to the syringe and mechanical 
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conditioning system. Mounting tubing connectors also helps keep the entire system in line, so fluid flows 
in one direction out of the syringe and the tubing is held taut off the bottom of the tissue chamber to 
prevent tissue ring damage. In the event of syringe tip or silicone tube failure, there would be no way to 
remove the 2mm blunt end metal syringe tip from the tissue chamber wall without replacing the entire 
tissue chamber. Similarly, if the silicone tube were to become worn out due to repeated use, damaged 
during autoclaving, or otherwise harmed, the 2mm metal syringe tip would have to be removed and 
replaced. 
 
Figure 22. Syringe-silicone tubing connectors 
Our plan to combat these problems was to use a two-tip, male-female luer fittings. The female tip would 
be secured into the wall of the tissue chamber and fixed there permanently, while the male tip would be 
permanently attached to the silicone tubing and lock onto the female tip during experimentation. The 
first male-female luer parts we considered were 1/16” inner diameter barbed luer-lock male and female 
tips (Figure 22) capable of interfacing with luer-slip syringes and silicone tubing.  The 1/16” inner 
diameter luer fittings is approximately 1.6mm, which is as close to 1.4732 mm inner diameter of the 
silicone tubing as standard parts would allow. The tight fit of the silicone tubing over the luer barb 
further aided in leak proofing the system. The wider opening of the luer tip leading into the narrower 
inner diameter of the elastic tubing caused some problems with tube failure when distended past 20% 
during testing. This gives the user the option to inflate the tube up to 120% of its original diameter in 
order to increase the strain magnitudes imparted on the tissue rings. Problems arose when we 
attempted to secure these luers into the wall of the tissue chambers. The luer pictured on the right in 
Figure 22 was nearly impossible to permanently mount into the tissue chamber wall. 
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Figure 23. Threaded syringe-silicone tubing connectors. 
Due to the problems encountered with the 1/16” inner diameter barbed luers, we considered 
alternative interlocking luers. We chose to use a ¼-28 threaded luer to fix into the tissue chamber wall 
that would interface with a 1/16” inner diameter barbed luer-lock tip (Figure 23). These luers allowed 
for permanent fixture into the tissue chamber and easily interfaced with the 1 mL syringes we had been 
using throughout bench top testing. The 1/16” inner diameter barbed luer-lock tip was heat shrunk to 
the silicone tubing in the same manner as described in Ali, 2009. The threaded luers were leakproof 
based on bench top testing over a period of 12 hours. This was accomplished by threading the luers into 
the tissue chambers, attaching a 1 mL syringe to the outside opening of the threaded luer, and filling the 
chambers with water. 
The fittings are manufactured from autoclavable plastics and come equipped with a barbed tip, which 
aids in securing the silicone tubing onto the luer fitting and prevents fluid flow beyond the barb. 
Leakproof testing involving manual fatigue testing of the luers under fluctuating silicone tube pressure 
for 20 minutes as well as 16 hours of motor-cam distension confirmed the ability of interlocking luer 
fittings to prevent fluid leakage from the system. By using both male and female luer fittings, we can 
change out overused or damaged silicone tubes for new ones without having to disassemble or replace 
any major components of the device. The female 1/16” inner diameter barbed bayonet fittings can be 
permanently connected to silicone tubing, autoclaved in single-use packets, used for experimentation, 
and then disposed of. The more easily replaceable standard parts we use in our design, the better the 
durability and lifespan of our device before standard wear renders it non-functional. 
6. Mechanism for attaching silicone tubing to syringe tip 
When preloaded with water and clamped at its free end, the silicone tube slides off of the syringe tip 
due to pressurization from depressing the syringe plunger. To attempt to correct this, we considered 
three different approaches for sealing the silicone tubing to the syringe tip(s) to prevent leaking and 
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detachment of the tubing.  First, a suture was tied around the silicone tube above the barb on the tip of 
the 1/16” female luer fitting (Figure 24). This method failed. Silicone glue was then applied to the tip 
shaft of the 1/16” female luer fitting below and above the barb. The silicone tube was then forced onto 
the luer tip over the barb and set to dry for 48 hours. A second sample using the 2mm blunt end metal 
syringe tips was also used. Silicone glue failed to prevent leakage at the syringe tip-silicone tube 
interface (Figure 24). 
 
Figure 24. Using sutures (left) and silicone glue (right) to attempt to seal syringe tips to silicone tubing 
Ali (2009) found an alternative to these methods. They used biocompatible 1/8” diameter, transparent, 
heat shrinkable tubing with a 2:1 shrink ratio to seal the silicone tubing to the rest of their pressurization 
system. After extensive testing involving preloading different syringes, luers, and silicone tubing with 
water, clamping the distal end of the silicone tubing, and pressurizing the tube past 20% distension 
(Section 5.1), we determined that heat shrink tubing was our best option and proved to prevent any 
leaking or detachment of the silicone tubing from the 1/16” female luer fitting. 
However, one limitation to this method exists. When manufacturing these syringe tip-silicone tubing 
parts, one must use a heat gun to adhere the heat shrink tubing to the syringe tip-silicone tubing 
junction by heating the heat shrink tubing above 175oC (see Appendix A for specific instructions). At 
such high temperatures, the plastic of the 1/16” female luer fitting begins to melt, potentially sealing the 
flow opening of the luer fitting. Excess heat directly applied to silicone tubing was observed to cause 
point defects along the affected section of tubing when the tubing was pressurized, causing plastic 
deformation and failure of the tube.  To avoid these complications, specific instructions have been 
outlined in Appendix B – A Guide to Heat Shrink Tubing for manufacturing these parts. Despite these 
limitations, heat shrink tubing is still the best option we tested for permanently sealing the silicone 
tubing to the syringe tip. 
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7. Silicone tubing sealing mechanism 
We had a variety of options for sealing the free/open end of the silicone tubing to ensure pressurization. 
These included endcaps, and a variety of different clamps. Endcaps are small rubber plugs fitted to the 
distal end of the silicone tube and held permanently in place with glue. We considered pinch clamps for 
small diameter tubing due to their ease of use, low cost, and autoclavability. 
The Ali MQP (2009) had a large variety of endcap designs including a needle endcap, blunt endcap, 
suture, and a combination of suture and a blunt endcap. The blunt endcap and needle endcap designs 
were multi-functional. Both aided in tissue ring loading by providing a point at the end of the silicone 
tube to place in the center of the tissue ring, from where you can push the ring up the silicone tube with 
forceps. The two endcaps also effectively sealed the silicone tubes from leaking due to air 
pressurization. Sealing the distal end of the tube may also pose a challenge in preloading the silicone 
tube with liquid for distension by syringe. The tube would have to be submerged completely in water or 
media to allow the air within the tube to be replaced with liquid before attaching the syringe. While 
these designs would have worked well in a vertical tissue chamber setting, they are far more difficult to 
accomplish in a horizontal setting. These may all seal the silicone tube effectively, but there is nothing 
present to hold the silicone tube taut and steady relative to the base of the tissue chamber.  Clamping or 
sealing the endcap inside the tissue chamber would keep the tube taut. 
 
Figure 25. Pinch clamp from World Precision Instruments (left) and Z-Man Corp (middle & right) 
For this reason, our silicone tubing sealing mechanisms were narrowed down to various types of clamps.  
We chose to clamp the tubing inside of the tissue chamber in order to prevent complications that could 
arise from running the tube outside, such as media leakage due to the presence of extra outlets in the 
walls of the chamber. Clamps effectively seal tubing without leaks and simultaneously can hold the 
tubing taut and off the bottom of the tissue chamber, securing its position in 3D space. The first type of 
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clamp we tested was a pinch clamp from World Precision Instruments (Figure 25, left). This clamp was 
100% leakproof based on pressurization testing involving distending silicone tubing with a syringe past 
20%, yet lost much of its flexibility post-autoclaving. This led us to a patent pending model for a pinch 
clamp from Z-Man Corp (Figure 25, middle and right). These clamps are autoclavable, and more 
importantly, retain their functionality post-autoclaving. The pinch-to-open mechanism for this clamp is 
far more ergonomic than the previous clamp, eliminating the need to hold the clamp steady with a 
second hand during opening. The seal on the silicone tube is visibly much tighter than the previous 
clamp as well. The hole located in the base of these clamps also makes it possible for us to manufacture 
a peg or dowel and hole to mount the clamps within the tissue chamber. This would make the clamps 
removable and eliminate the need to permanently adhere the clamps to the chamber surface, which is 
helpful in the event of clamp malfunction or during sterilization of individual parts. The smaller 
ergonomic pinch clamp was chosen for our device due to size restrictions within the tissue chamber. 
8. Tissue chamber materials 
Our options for tissue chamber materials were limited by the fact that the material had to be 
biocompatible, autoclavable and/or sterilized by 70% ethanol, easily machinable, and relatively 
inexpensive. We needed to choose a type of plastic for our tissue chambers, base component of our 
design, removable tray, and tissue chamber lids. 
  
Figure 26. Ultra-high molecular weight polyethylene (left) and polycarbonate (right) 
We decided to use ultra-high molecular weight polyethylene (UHMWPE) (Figure 26, left) for our tissue 
chambers due to its’ high impact strength and durability, weather resistance (humid incubator 
environment), operating temperature range of -40oF to 275oF (250oF needed for autoclaving), and that it 
meets ASTM (D4020, D4976, and D6712), FDA, and USDA specifications. Although this material does not 
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fulfill the need for transparency of the material to allow visualization of the sample within the chamber, 
transparent tissue chamber lids will satisfy this requirement.  
We decided to use transparent abrasion-resistant polycarbonate (PC) (Figure 26, right) for the base and 
removable trays of our device. Based on client interviews, we discovered that the base and tray of our 
device need not be autoclaved between uses because they will not be in direct contact with tissue 
samples. It would merely need to be wiped down with 70% ethanol before entering the incubator. For 
this reason we chose abrasion-resistant polycarbonate to withstand harsh cleaners and solvents. PC also 
has high impact strength and durability, is weather resistant, and has an operating temperature range of 
-40oF to 200oF. Due to its low operating temperature, it cannot be sterilized within an autoclave (250oF), 
and was thus not considered in designing tissue chambers. 
Materials were selected based on several characteristics such as biocompatibility, sterilizability, size, 
ease of use, and how well they interface with other components in the device. Using these material 
choices, we designed and prototyped a device to mechanically condition tissue engineered blood vessels 
in vitro. The efficacy of individual materials and interfaces between design components were then 
tested through a series of qualitative and quantitative bench top experiments. 
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Chapter 5 – Design Verification 
 
To validate specific features of our design we categorized the desired functions into two categories: 
those functions to be conducted by the tissue chamber and those to be accomplished by the mechanical 
conditioning system. The experiments used to determine the appropriate means for these features are 
explained in the following chapter. 
5.1 Syringe Selection 
We considered three different types of syringes that were readily available to use as a means of 
displacing specific volumes of water into the silicone tubing of our device to achieve 10 ± 1% distension. 
The three syringes we examined were: sterile Monoject® 3mL luer-lock syringes, sterile 1mL luer-lock 
syringes, and sterile Monoject® 1mL “push-connect” or luer-slip syringes, all pictured in Figure 27. The 
volume of water required to achieve ~10% distension for a 10 cm long, 1.9578 mm inner diameter 
autoclaved silicone tube was found to be approximately 0.075 mL through extensive bench top testing 
of multiple samples. This volume was measured through observing the specific volume displaced by the 
1 ml syringe that resulted in 10% distension of the outer diameter of the silicone tube. The experiment 
was performed by filling a 1 ml syringe with water completely, tapping all air bubbles out of the syringe 
barrel, and attaching two interlocking male and female luers. The female luer was heat shrunk to 10cm 
of silicone tubing (see Appendix # for manufacturing instructions). The system was flushed with water 
until the plunger read 0.3mL and clamped at its distal end with a pinch clamp. We used approximately 
0.3 mL of water to preload the silicone tube and connectors prior to sealing the distal end of the tube 
and pressurizing it. Due to using such a small volume of water (0.3mL + 0.075mL + a safety factor of 
0.225mL = 0.6mL), we limited our syringe options to between 1 and 3 mL syringes. The safety factor was 
used in the event that the user accidentally pushed the syringe plunger too hard and ejected too much 
water. It also allows for a larger cam to be used in our design further on, leaving room on the syringe 
barrel for larger volumes of water to be displaced by larger cam sizes in future studies. 
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Figure 27. 3mL luer-lock syringe (left), Luer-slip vs. luer-lock syringe tips (right) 
 The 3mL Monoject® syringes came pre-packaged and sterilized. The barrel of the syringe was marked at 
0.1mL increments, 0.1mL corresponding to 0.06 mm of space between graduations. The overall length 
of the syringe from luer-tip to plunger base is 80 mm when the syringe plunger is fully depressed, and 
84.5 mm when at a pre-distension volume of 0.3mL, the safe minimum volume used for distension 
studies. It would require 1.5mm (0.075mL on a 3mL syringe ≈ 1.5mm) of syringe plunger movement to 
achieve ~10% distension in the attached silicone tubing. The tip of the syringe is fitted with a luer-lock 
which secures luer-based syringe tips to the syringe by twisting the detachable tips onto the barrel of 
the syringe. This ensures that the syringe tips remain attached during use and prevents the syringe tips 
from being pulled from the syringe when a force is applied. 
 
Figure 28. 1 mL push-connect or luer-slip syringe 
The 1mL luer-lock syringe is identical to the 1mL “push-connect” or luer-slip syringe with the exception 
of the luer fitting at the tip of the syringe. A side-by-side comparison of luer-slip and luer-lock syringe 
tips can be seen in Figure 28. One mL luer-slip and luer-lock syringes come pre-packaged and sterilized. 
The barrels of these syringes are marked at 0.01mL increments, 0.01mL corresponding to ~0.017 mm of 
space between graduations. The overall length of the syringe from luer-tip to plunger base is 91.5 mm 
when the syringe plunger is fully depressed, and 109.5 mm when at a pre-distension volume of 0.3mL. 
Further fatigue testing indicated that the shorter the syringe plunger during mechanical conditioning 
with the motor, cam and spring, the less likely the plunger is to bend and permanently deform over a 
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period of 2 days constantly running within an incubator. The safety factor was thus later changed to 
0.125mL instead of 0.225mL so the plunger would travel from the 0.2mL point to 0.125mL instead of 
from 0.3mL to 0.225mL, decreasing the overall length of plunger left unsupported by the syringe barrel.  
Due to these factors (summarized in Table 4), we decided to use a 1mL syringe in our design. The 4.5 
mm (0.075mL on a 1mL syringe ≈ 4.5mm) distance required by the 1mL syringe to inject 0.075mL of 
water into the silicone tubing to achieve ~10% distension makes it far simpler to manufacture and 
operate the cam. It is more difficult to move a syringe by 1.5mm (3mL syringe) than by 4.5mm (1mL 
syringe). The larger working area over which to mechanically distend the silicone tubing is preferred, 
making it possible for us to use a larger cam if necessary. The 1mL syringe also has far smaller 
measurable volume increments along the barrel of the syringe, making it far simpler to measure small 
volume changes in the system. Between the luer-slip and luer-lock 1mL syringes, we decided to use a 
1mL luer-slip syringe as seen in Figure 28. The 1mL luer-lock syringes we viewed for comparison in 
catalogs were bulkier at the tip than the luer-slip. The twist required to secure the luer-lock syringe tips 
into place was trivial compared to a push-connect tip. Locking luers were an unnecessary precaution 
that would add an additional complication to loading and preparing silicone tube samples during 
procedural set-up. 1mL luer-slip syringes are autoclavable, reusable, and inexpensive at roughly 17 cents 
per syringe. 
Table 4. Summary of syringe characteristics 
Syringe Type Length of Syringe 
(Plunger Depressed) 
Distance Traveled for 
0.075mL Injection 
Syringe 
Accuracy 
Luer Attachment 
1mL luer-slip 91.5 mm 4.5 mm 0.01 mL Push 
3mL luer-lock 80.0 mm 1.5 mm 0.1 mL Push & Twist 
1mL luer-lock N/A 4.5 mm 0.01 mL Push & Twist 
 
5.2 Quantification of Displaced Volume  
 
We tested our design alternatives to determine which approach was best suited at achieving 10% 
distension. Having decided upon a water-based pressurization system, rather than compressed air, we 
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needed to determine the volume of water required to distend a silicone tube. Specifically, our design 
called for a silicone tube 10 cm in length for optimal tissue sample loading. 
5.2.1 Experimental Procedure 
To measure the volume of water displaced by the 1 mL syringe that achieved the target magnitude of 
10% distension, a water-filled syringe was used to statically inflate a tube with defined volumes in 
increments of 25 μL (Figure 29Error! Reference source not found.). Tubing diameters were obtained 
from still images of the inflated tubes using a Leica EZ4 D microscope and Leica Application Suite. For 
this experiment a total of 5 autoclaved samples were tested.
 
Figure 29. 1 mL luer-slip syringe connected to 1/16” barbed bayonet tip mated with a 1/16” barbed luer-lock tip that is 
attached by heat shrink tubing to a 10 cm silicone tube sample. A pinch clamp at the distal end of the tube was used as a 
means of fixation and sealing. 
 
5.2.2 Experimental Results 
In static inflation tests, 75 μl of water resulted in 9.80±0.23% distension of a 10 cm length of 1.96 outer 
diameter silicone tubing (Figure 30Error! Reference source not found.). Therefore, a 75 μL displacement 
volume was used for subsequent studies.  
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Figure 30. Required volume to achieve 10% distension of silicone tubing (n = 5; 9.8±0.23%). Red lines represent desired max 
and min distension values. Green line represents target value (10% distension). 
 
5.3 Uniformity of Tubing Distension 
The goal of this experiment was to determine how uniform the distension was along the length of the 
silicone tube. This allowed us to visualize the amount of working space for the placement of tissue rings.  
 
5.3.1 Experimental Procedure 
We marked each sample with nine markings (numbered 0-8) with 1 cm spacing between them (Figure 
31). Then, similarly to the Quantification experiment, we statically distended the silicone tube by 
injecting 75 μL and measured the induced diameter by taking an image through the Leica Software. This 
was repeated for every reference point along the length of the tube. 
 
Figure 31. A 1 mL luer-slip syringe connected to a 1/16” barbed luer lock tip fixed to 10 cm silicone tube sample by heat 
shrink tubing. The 10 cm sample is marked with a black marker sealed and by a pinch clamp. 
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5.3.2 Experimental Results 
 
Static inflation of autoclaved tubing samples (n=20) suggested that 10 ± 1% distension could achieved. 
Five reference points (points 2-6) were found to always be within 10±1% distension. After an injection of 
75 μl of fluid, all points were within 10 ± 1.6% (Error! Reference source not found.Figure 32). 
 
Figure 32. Uniform distension along silicone tubing (n=20). Red lines represent desired max and min distension values. Green 
line represents target distension (10%). 
5.4 Tissue Ring Loading  
5.4.1 Experimental Procedure 
To verify the desired objectives of a high throughput and easy sample loading, four tubing samples were 
each loaded with 4-6 TEBV rings (Figure 33) and secured within our tissue chamber.  
 
Figure 33. Six tissue rings loaded onto silicone tubing. 
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The chambers were filled with culture media and placed in the tissue chamber housing unit (Figure 34). 
For a complete procedure, see Appendix E. 
 
Figure 34. Tissue rings (A) mounted on silicone tubing (B) and loaded into the tissue chambers (C). 
5.4.2 Experimental Results 
Tissue ring samples (n=45) were successfully mounted (45/53; 85% success rate) onto 4 silicone tubes 
(n=4-6 per tube). After 3 and 7 day conditioning periods, samples remained viable and uncontaminated. 
5.5 Preliminary Impacts of Mechanical Conditioning 
5.5.1 Experimental Procedure 
 
Using the experimental procedure outlined in Appendix E, four tissue chambers were prepared. In two 
of the four chambers, rotating cams were turned on to induce mechanical conditioning while the other 
two were left off and represented static culture control samples. The four chambers where then placed 
into the bioreactor system and run for two different time periods. One set, consisting of a static and 
conditioned chamber, was allowed to culture for 3 days while the other ran for a total of 7 days. To 
ensure that the cell constructs received proper nutrients, the media (DMEM, 1X with 4.5 g/L glucose, 
L-glutamine, & sodium pyruvate – modified with 10% FBS, 1% Penicillin/Streptomycin - 60 mL 
per chamber) was changed every two days. Following the end of the culture periods, the tissue rings 
were harvested for uniaxial tensile testing and histology to measure ultimate tensile stress (UTS), 
thickness, and cell density. Thickness was measured using DVT Imaging Software while UTS was 
A 
B 
C 
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determined through the use of an Instron machine. The static samples were compared to the 
conditioned samples to determine the effectiveness of our device. 
5.5.2 Experimental Results 
 
Two individual trials were conducted, each consisting of two time points (3 and 7 day), in which both 
static (control) and mechanically conditioned (experimental) samples were examined for UTS, thickness, 
and cell density.  
For the first trial (Figure 35) the average UTS of unconditioned samples after a three day culture period 
was 555.92 ± 129.78 kPa, whereas conditioned samples after 3 days were found to have a mean UTS of 
429.60 ± 107.33 kPa (p = 0.19, therefore not statistically different). For the 7 day samples, 
unconditioned rings were found to have a UTS of 82.79 ± 13.29 kPa while the conditioned rings were 
measured to have a UTS of 122.42 ± 32.96 kPa (p = 0.052, therefore not statistically significant).  The 
UTS for both static and conditioned ring samples were significantly stronger at 3 days compared to 7 
days (p<0.001).    
 
Figure 35. Ultimate tensile strength first trial. N-values are 2, 3, 2, and 4, respectively. 
These calculations were repeated for the second trial (Figure 35). After three days of culture, the static 
samples exhibited an average UTS of 128.23 ± 36.8 kPa, whereas the conditioned samples were found 
be able to withstand 160.27 ± 31 kPa before failing (p = 0.18, therefore not statistically different). After 
seven days of culture, the static samples experienced a UTS of 84.19 ± 19.4 kPa compared to the 
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conditioned samples which had a mean UTS of 84.9 ± 8.9 kPa (p = 0.48, therefore not statistically 
different). All day 3 samples were compared to all day 7 samples; this statistical comparison yielded a p-
value of 0.004, therefore confirming a statistical difference between the strengths of the samples. As 
before, the only conclusion that could be made was that the strength statistically decreased from 3 to 7 
days. The p values for the other groupings were too low to determine statistical differences. 
 
Figure 36. UTS second trial. N-values are 3, 3, 2, and 3, respectively. 
In addition to UTS, we also measured the mean thickness of the unconditioned and conditioned 
samples. Displayed in Figure 37 are the results from these experiments. The average thickness of static 
samples after 3 days in culture was 0.491 ± 0.069 mm, and the 3 day conditioned samples’ average 
thickness was measured as 0.548 ± 0.045 mm (p = 0.16, therefore not statistically different). After 7 days 
in culture the static samples were found to have an average thickness of 1.045 ± 0.19 mm, whereas the 
conditioned rings had a mean thickness of 1.041 ± 0.078 mm (p = 0.47, therefore not statistically 
different). All day 3 samples were compared to all day 7 samples; this statistical comparison yielded a p-
value of 3.43 E-6, therefore confirming a statistical difference between the thicknesses of the samples.  
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Figure 37. Thickness first trial. N-values are 2, 3, 2, and 4, respectively. 
Thicknesses were also measured for the second trial (Figure 38). After three days of culture, the average 
thicknesses for static and conditioned samples were calculated to be 0.7018 ± 0.05 mm and 0.72 ± 0.02 
mm, respectively (p = 0.20, therefore not statistically different). After being cultured for seven days, the 
thicknesses of the rings increased to 1.08 ± 0.08 mm for the static samples and 1.154 ± 0.09 mm for the 
conditioned samples (p = 0.10, therefore not statistically different). All day 3 samples were compared to 
all day 7 samples; this statistical comparison yielded a p-value of 9.6 E-10, again confirming a statistical 
difference between the thicknesses of the samples.  
64 | P a g e  
 
 
Figure 38. Thickness second trial. N-values are 5, 6, 6, and 5, respectively. 
5.6 Histological Analysis 
Rat aortic smooth muscle tissue rings (WKY 3M-22) were harvested at 3 and 7 days (Figure 39) for both 
sample sets.  
 
Figure 39. Conditioned (A) and static (B) tissue rings on silicone tubes after 7 days of culture. 
The tissues were sectioned, mounted, and stained with hematoxylin and eosin and imaged under 20x 
magnification. Cell count and area of the tissue in square millimeters were calculated using ImageJ 
software. Mechanically conditioned samples yielded a density of 12.28 cells/mm2 after 3 days (Figure 
A 
B 
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40- A) and 18.26 cells/mm2 after 7 days (B). Static samples yielded densities of 22.16 cells/mm2 (C) and 
15.87 cells/mm2 (D) after 3 and 7 days, respectively. Data is based on sample sizes of 2 for each time 
period and culture condition with the exception of conditioned 7 days, which had 1 sample. This 
preliminary analysis suggests that cell density increased by 49% from three to seven days for 
conditioned samples, while static samples exhibited a decrease of 29% cell density according to ImageJ 
calculations. 
 
Figure 40. 3 and 7 day tissue ring samples stained with hematoxylin and eosin at 20x magnification. 
Collagen staining was also conducted using Fast Green/Picrosirius Red for all tissue ring samples (Figure 
41). Upon review under 20x and 40x magnification, little to no collagen appeared to be present. In order 
to definitively make a conclusion, the samples should be recut deeper into the tissue rings, or use a 
biochemical assay to quantify the amount of collagen in each ring sample. 
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Figure 41. Tissue samples stained with Fast Green/Picrosirius Red at 40x magnification. 
Overall, all tissue rings maintained a high cell density, remained viable, and were uncontaminated for all 
sample sets.  
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Chapter 6 - Discussion 
Each component of the final assembly was designed to meet or help meet a project objective or 
constraint, including being easy to use and assemble, achieving the desired distension along the silicone 
tube, providing a sterile culture environment for tissue samples, and offering a number of customizable 
features to the user. Also, as our device promotes advances in medicine and patient wellness, it 
addresses several greater social and ethical concerns. 
6.1 Bioreactor design 
6.1.1. Successfully achieved 10±1% distension 
The silicone tube was statically inflated and changes in outer diameter were measured in order to 
calculate the percent distension. It was determined that the displacement of 75µL of water by the 1 mL 
syringe would yield an average distension of 9.8 ± 0.2%. 
6.1.2. Uniformity of distension leads to high throughput 
The preloaded 10 cm silicone tube was marked at every centimeter and subjected to inflation of +75µL. 
While the tube exhibited inconsistent distension values at the proximal and distal ends, 10±1% 
distension was consistently achieved at markers 2-8. This suggested that the tube achieves uniform 
distension across at least 6 cm; thereby defining the length of usable tubing on which tissue rings may 
be loaded and conditioned. In a client interview, it was determined that six tissue samples could be 
loaded on each silicone tube. Therefore, the bioreactor may culture and condition a total of 30 tissue 
samples simultaneously. 
6.1.3. Customizability 
The bioreactor is designed so the user can run up to five isolated systems at one time. Each unit has its 
own mechanical conditioning system; the main components of this system are the motor and cam. The 
motors interface with a set of power switches so some motors may run at 60 RPM while others are shut 
off. This also presents the possibility of conditioning individual samples in intervals (e.g., one hour on, 
one hour off). The size of the cam may also be changed in order to adjust the volume of medium 
displaced by the syringe. A smaller cam will displace a smaller flow volume, and likewise a larger cam 
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will displace a larger volume. The individual tissue chambers provide isolated culture environments for 
each set of tissue rings. The user may adjust the type of culture media and additives in each system. 
6.1.4. Device and materials are biocompatible 
After 3 and 7 day culturing periods, cells remained viable and healthy without evidence of 
contamination. This is partially due to the biocompatible and sterilizable material choices (UHMWPE, 
sterile syringes, stainless steel dowels, polypropylene pinch clamps). Additionally, the tissue chamber’s 
loose-fitting Petri dish-style lids allow gas exchange, and the removable tray allows the samples to be 
easily transported to a biosafety cabinet where cell culture media can be replenished. Finally, the 
bioreactor meets the defined size constraints and is able to fit in an incubator. 
6.1.5. Easy to secure and remove samples 
During the loading phase of cell testing, 88% (21 of 24) of tissue engineered blood vessel rings were 
successfully loaded onto the silicone tube. This confirms that the 10 cm silicone tube (OD=1.968, 
ID=1.9558) successfully houses the tissue rings and provides a simple, user-friendly assembly platform. 
Furthermore, the luer fittings allow the user to access the tubing and rings which facilitates the loading 
and unloading of culture samples into and out of the tissue chambers. 
6.1.6. Time and budget met 
The entire bioreactor was designed and manufactured within the 21 week time constraint, and the team 
produced a working prototype for less than the $368 budget. 
6.2 Economic impact 
This bioreactor design has the potential for economic impacts in the research community and in clinical 
use. The bioreactor was manufactured for less than $400. For comparison, the Harvard 22 Syringe Pump 
which uses two syringes compared to five and may only contribute as a single component of other 
bioreactor designs is advertised as the industry standard and costs over $3000 (Harvard Pump 22, 2010).  
The production of our high-throughput bioreactor would supplement the production rate of cell culture 
and research. This may lead to earlier FDA approved TEBV grafts that could be used to treat 
cardiovascular disease. As these types of grafts would consist of tissues that are derived from the 
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patient, fewer instances of rejection can be expected. This will ultimately result in the user enduring 
fewer costs associated with pharmaceuticals, follow-up procedures, and hospital stays. 
6.3 Environmental impact 
The bioreactor is composed primarily of durable plastics that are abrasion resistant and may be 
sterilized in an autoclave, with the only exceptions being bulk products such as pinch clamps and luer 
fittings. The use of sterilizable, reusable materials minimizes the waste production associated with the 
device. 
6.4 Societal influence 
According to the World Health Organization (WHO, 2010), heart disease is the second leading cause of 
death in the world, killing about 2.5 million people annually. The development of patient-derived TEBV 
grafts could therefore have a positive impact on a tremendous number of patients worldwide. 
6.5 Ethical concerns 
The use of laboratory animals as models for experimental purposes is a common topic of debate. Tissue 
engineered constructs grown in vitro offer an alternative to animal models during research and 
development. Furthermore, this device and all relevant research may lead to saving lives and improving 
the conditions of millions of patients. 
6.6 Health and safety issues 
Our bioreactor facilitates research that may develop usable, patient-derived blood vessel grafts. Self-
derived grafts are generally safer than synthetic grafts or donor transplants, where mechanical failure, 
infection, compliance mismatches, and rejection of the graft are prominent issues. The production of 
this bioreactor and the resultant TEBVs will ultimately lead to advances in the medical industry and 
improved patient care. 
6.7 Manufacturability 
The bioreactor primarily consists of components that can be machined using high-speed milling 
techniques and a series of machining files. Most other components in the bioreactor are standard parts 
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that can be purchased from catalogs, such as luer fittings, silicone tubing, and 12V hobby motors. 
Minimal assembly is required by the user, and all assembly only requires simple common tools such as a 
screwdriver. 
6.8 Sustainability 
The plastics that are used in the body of the bioreactor (UHMWPE and polycarbonate) are both 
recyclable materials. Machining scraps and even the device itself can be reprocessed and used for other 
applications, thereby minimizing the amount of waste produced in the production and use of the 
bioreactor.
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Chapter 7 – Final Design & Validation 
A computer-generated drawing of the final design assembly is shown in Figure 42. A photograph of the 
final design assembly is show in Figure 43. 
The primary architecture of the assembly consists of a polycarbonate base (Figure 42 & Figure 43 - 1). 
The surface of the base contains four corner barriers (2) to hold a polycarbonate tray (3). The tray has 
been machined to contain five wells in which milled ultra high molecular weight polyethylene 
(UHMWPE) tissue chambers sit (4). Each chamber houses a series of threaded luer fittings that are fitted 
with a 10 cm, 1.968 mm outer diameter silicone tube. The distal end of the tube is clamped shut using a 
polypropylene pinch clamp, which is secured to the bottom of the chamber using a 1/8” stainless steel 
dowel (see Section 4.2.2 - 3). 
 
Figure 42. Final design (CAD) 
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Figure 43. Final design 
The base also contains five hose clamps (5) and a milled section in which five 12V 60 RPM hobby motors 
are mounted (6). Each motor contains a cam and interfaces with a reverse-engineered 1 mL syringe 
pump (7) as described in 4.1.1-4. The design’s mechanical conditioning component consists of five 12 
volt, 60 RPM gear-box hobby motor (Figure 42 & Figure 43Error! Reference source not found. - 8) which 
s fixed with a circular cam (9). As the cam rotates, it depresses the plunger of the fixed 1-mL syringe 
(10). It has been determined that the distance the plunger needs to be depressed in order to displace 
enough water to provide a 10% distension in the silicone tubing is 4.5 mm. Therefore, the axis of 
rotation for the cam is offset from the center by 4.5 mm.  
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Between the plunger head and the syringe body is a spring (11) which allows the plunger to retract as it 
is in contact with the short leg of the cam. This essentially creates a syringe pump. When interfaced with 
the silicone tubing through the luer fittings in the new tissue chamber design, the displacement of the 
syringe plunger will cause the silicone tubing in the tissue chamber to distend (the amount of distension 
depends on the size of the cam).  
Both the tray and the base can be manufactured using high speed milling techniques. This assembly was 
chosen as the final design because its materials and architecture helps maintain the stability of the 
assembly. Also, the base internalizes most of the mechanical components in the design. Furthermore, 
the removable tray provides a definable housing unit for the tissue chambers and allows the user to 
easily remove and transport all tissue chambers at once. 
These design aspects are appealing to both the designer and user because the small, individualized 
motors minimize the size of the entire design while allowing for customizability and individual shutoffs. 
Also, by having isolated a single mechanical failure is not likely to compromise the whole system. The 
removals of the wheel and flat arm are also expected to decrease failure rates as there are fewer 
mechanical interfaces in the system. Finally, this component of the design allows for increased 
customizability; while the cam has been designed to displace only enough water to distend the silicone 
tubing (and therefore the TEBV samples) by 10%, this cam may simply be changed out with another of a 
larger diameter to provide greater distension of the tubing. 
Figure 44. Mechanical stimulation. 
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The final design component is the tissue chamber compartment. This design is preferred to the other 
design alternatives because it completely separates the silicone tubing and pinch clamping from the 
mechanical system and the environment, and therefore significantly reduces the risk of contamination. 
Also, the use of the luer fittings allows for easy removal and attachment of silicone tubes and TEBV 
samples. 
Our device offers several unique features that overcome the limitations of current devices. Our device 
offers high throughput options by allowing for the conditioning of up to 30 tissue rings simultaneously. 
The device has also been designed so the cam, syringe, and silicone tubing can be removed and replaced 
with different sized components in order to adjust the flow volume and frequency, and to accommodate 
different sized tissue rings. Tissue chambers are isolated from one another and the motors run 
independently. This allows several different culture conditions and experimental variables to be altered 
during a single experiment. Standard replaceable parts have been incorporated into the design in order 
to allow the user to easily replace damaged or contaminated components. Internalizing the motors in 
the polycarbonate base helps align and secure several design components. Internalized motors keep 
mechanical systems separate from tissue chambers so they may remain within the incubator while the 
tissue samples are transported for feeding using the removable tray. 
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Chapter 8 – Conclusions and Recommendations 
Through component verification and bench top tests, both aspects of the bioreactor were validated: the 
mechanical conditioning system and the tissue chamber. This validation is proof-of-concept suggesting 
that the bioreactor could be used to successfully impart mechanical conditioning on tissue engineered 
ring samples. 
8.1 Design Features  
The design of a novel bioreactor which cyclically imparts mechanical conditioning was accomplished. 
The preliminary tests in conjunction with the bench top validations lead to the conclusion that a 10 cm 
long silicone tube sample could uniformly be distended by ~10% and therefore can impose cyclic 
circumferential strain on tissue engineering ring constructs.  
Compared to other devices currently available, our bioreactor design is beneficial because it allows for a 
great deal of variability and customizable features. Changes in culture conditions can be varied by 
altering the dimensions of the easily replaceable cam component of the mechanical stimulation system. 
Additionally the individual tissue chambers allow several culture media conditions to be altered at once. 
Motors run independently from one another so several static and mechanically conditioned samples can 
be cultured simultaneously and for different periods of time.  
Another benefit to our device is that with the total number of tissue chambers, a high throughput is 
achieved. Our device is capable of housing up to six tissue rings per chamber and the entire system is 
capable of maintaining five chambers yielding in total 30 tissue rings being conditioned in vitro during a 
single experiment.  
8.2 Future Recommendations  
Having conducted one successful full system experiment the team has developed the following 
recommendations.  
The current hose clamps being used as syringe holders are very stiff and have been shown to crack over 
time with repeated use. We suggest that an alternative be designed or purchased. Even though the hose 
clamps successfully support the syringe during the conditioning cycles, it is very difficult to insert and 
76 | P a g e  
 
remove the syringe barrels. Metal syringe holders would be an appropriate alternative to the current 
holders. Additionally, the syringe plunger was found to be prone to deformation due to the high levels 
of shear stress created at the plunger and cam interface. We suggest that either a metal syringe or a 
stiffer syringe be used.  
Small amounts of leaking were also observed in two of the four chambers during testing. It was 
determined that an adjustment of the threaded luer located in the wall of the tissue chamber resolved 
this issue. However, in order to avoid this from occurring during future experiments we suggest that a 
rubber o-ring be placed around the thread of the luer. Another alternative could be to permanently fix 
the threaded luer into the wall of the tissue chamber, preventing the possibility of user error during 
assembly.  
Even though the team experienced no contamination during our week long experiment, we suggest that 
tissue chamber lids be machined with overhang rather than the current design’s lids which simply rest 
on top of the tissue chambers. We feel that this will aid in the prevention of spilling during transport 
from biosafety cabinet to incubator and will further reduce the chance of contamination. 
During the manufacturing stage we learned that the UHMWPE sheets used for the tissue chambers was 
a relatively soft plastic compared to other materials available in the market. For our purposes, the 
material was sufficient, however it was not the easiest to machine due its softness. We recommend that 
alternative plastics be considered to avoid issues with milling, tapping, and cutting. 
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Appendix A – Pairwise Comparison Chart (PCC) 
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size of 
ring/tube 0   0 0 0 0 0 0 1 1 2.94% 
High 
Throughput 0 1   1 0.5 0.5 0 0 1 4 
11.76
% 
Programma
ble 0.5 1 0   1 1 0 0.5 1 4.5 
13.24
% 
TEBVs 
easily 
secured 0 1 0.5 0   0.5 0 0 1 3 8.82% 
TEBVs 
easily 
removed 0 1 0.5 0 0.5   0 0 1 3 8.82% 
Media 
supply 1 1 1 1 1 1   1 1 7 
20.59
% 
Waste 
removal 0.5 1 1 0.5 1 1 0   1 5.5 
16.18
% 
Inexpensive 0 0 0 0 0 0 0 0   0 0.00% 
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Appendix B – A Guide to Heat Shrink Tubing 
 
Goals: 
 Effectively seal silicone tubing to 1/16” inner diameter male barbed bayonet luer fittings 
Materials: 
 Scissors/scalpel 
 Heat gun (preferably with low and high heat settings) 
 Tweezers/forceps 
 Gloves 
 Biocompatible heat shrinkable tube (1/8" diameter) 
 Silicone tubing 
 Male barbed bayonet luer fitting for 1/16" inner diameter tubing 
Procedure: 
1: Using gloves to handle the silicone tubing, cut the tubing to desired length (10cm) 
Note: For more accurate, clean cuts, use a scalpel on a flat surface alongside of a measuring device 
2: Cut heat shrink tubing to desired length (3-5mm or long enough to cover the barb and silicone tubing 
on the luer fitting) (see Figure below for approximate scaled sizing) 
 
3: Using gloves to handle the silicone tubing, attach the silicone tubing to the barbed end of the luer 
fitting, ensuring that the tubing is secured above the barb (see Figure below) 
 
4: Using gloves, cover the silicone tubing and barbed tip overlap with heat shrink tubing (see Figure 
below) 
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5: Remove your gloves (in case of heat exposure) and use tweezers/forceps to pick up the luer fitting by 
its’ hollow end (see Figure below) 
 
6: Position the heat gun pointing away from yourself and turn it on (depending on the type of heat gun 
used, this may require an additional person to hold the heat gun while the original person completes 
steps 7-9) (see Figure below for model heat gun we used) 
 
7: Hoist the silicone tubing—heat shrink tubing—luer fitting combination approximately 1.5 inches from 
the mouth of the heat gun using the tweezers/forceps and spin continuously for 10-30 seconds to 
adhere the heat shrink tubing to all sides of the luer fitting (*BEWARE of melting the luer fitting due to 
positioning the parts too closely to the heat gun) (see Figure below) 
 
8: Repeat for multiple tubing assemblies 
9: Switch the heat gun to the cool setting for a minimum of one minute before shutting the heat gun off 
and storing it  
86 | P a g e  
 
Appendix C – A Guide to Wiring and Sealing Motors 
 
Potting and Sealing Motors 
Materials:  
 12 V 60 RPM DC motor (x5) mounted into motor mount 
 Epoxy, hysol M-121hp medical device epoxy adhesive (50 mL) 
 Hysol adhesive for encasing, urethane, (50 mL) 
 Potting gun 
 Easy-ID low voltage cable, 24/2 AWG, 0.11” W x 0.06” thick, 12 VDC, 50’ L 
 Wire cutters 
 Heat gun 
 Soldering kit 
 Vice 
 Moisture-seal polyolefin heat-shrink tubing, 1.5” ID before, 0.75” ID after – cut into 2.5” lengths 
(x5) 
 Small diameter heat shrink tubing for wiring 
Procedure (Note – do everything listed for each motor individually): 
1. Cut wire to 6 foot lengths 
2. Strip wire and fix to motor leads 
3. Solder wire to motor leads 
4. Heat shrink positive and negative wires near soldering point to prevent further separation of zip 
wire 
5. Secure motor mount into vice facing upside down with wires coming out the top 
6. Pot motor holes with epoxy hysol M-121 medical device epoxy and potting gun 
7. Once all motors have been potted, flip motor mount in vice so epoxy drips down wires (and not 
into motor) 
8. Let dry for 6 hours 
9. Attach moisture-seal heat-shrink tubing to outside of motors (encasing both the gearbox and 
motor) 
10. Use heat gun to permanently attach tubing around motor 
11. Fill remaining area within heat shrink tubing with hysol adhesive for encasing 
12. Position wires in the same direction perpendicular to the long side of the motor mount and 
pinch the heat shrink tubing and hysol adhesive encasing closed around the wire 
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13. Let dry for 24 hours 
Before: 
 
After: 
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Wiring Motors to Power Supply 
Materials:  
 Motors sealed into motor mount and base 
 5-hole 22mm button enclosure, plastic 
 Selector switch, 22mm, plastic (x5) + contact blocks 
 Easy-ID low voltage cable, 24/2 AWG, 0.11” W x 0.06” thick, 12 VDC, 50’ L 
 Wire cutters 
 Wire connectors (male and female pins) (x10) 
 16 AWG power cable 
Procedure: 
1. Assemble the button enclosure as per instructions given with purchase 
2. Measure, cut, and strip (all wires should look like this when stripped) the ends of four 5 cm long 
pieces of positive (red) 24/2 AWG 12 VDC wire (see Figure below) 
 
3. Attach and screw the pieces of wire between the 5 selector switches (see blue arrows in Figure 
below) 
 
Wire 
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4. Measure, cut, and strip the ends of five pieces of positive (red) 24/2 AWG 12 VDC wire so all 
wires feed out of the same side of the 5-hole 22mm button enclosure and end at approximately 
the same point (see Figure below) 
 
5. Attach and screw one length of wire to each contact block (see Figure below) 
 
6. Strip the other end of the same lengths of wire and crimp push-in wire connector pieces to the 
ends of each wire and fit into plastic alignment case, ensuring wires of the same color are all 
secured on the same side 
7. Cut and strip 5 lengths of negative (black) 24/2 AWG 12 VDC wire to equal lengths 
 
 
Screw in Here 
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8. Crimp push-in wire connector pieces to the ends of these lengths of wire and fit into the same 
plastic alignment case, ensuring wires of the same color are all secured on the same side (see 
Figure below) 
 
9. Cut and strip a 60 cm length of wire (still zip connected together) and attach one end of the 
negative (black) wire and positive (red) wire to the power supply and secure with a screw (see 
orange box in Figure below) 
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10. Cut and strip a 5 cm long piece of negative (black) wire and twist together with all other free 
ends of negative (black) wires, securing together with tape (see Figure below) 
 
11. Attach the free end of the positive (red) wire to the contact block nearest the 22 mm button 
enclosure’s exit hole (see orange arrow in the Figure in step 3) 
12. Attach the 16 AWG power cable to the power supply (see green box in Figure in step 9) and 
cover all wires with electrical tape 
13. Strip free ends of 6 foot long wire sealed into 60RPM 12V DC motors and crimp push-in wire 
connectors onto lengths of wire and fit into plastic alignment case, ensuring wires of the same 
color are all secured on the same side (see Figure below) 
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Final Product: 
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Appendix D – Building Our Device 
The following engineering drawings profile the geometry and dimensions of the components of the 
device that were machined. These include the tissue chamber, base, motor mount, and removable tray. 
All of these components were manufactured from raw plastic sheets using high-speed milling 
techniques in a HAAS automated mill.  The following models and dimensions were programmed using 
SolidWorks and FeatureCAM softwares, and were uploaded into the mill’s computer system. 
 
HAAS Milling Machine 
 
Partially Milled Tissue Chamber 
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Tissue Chamber 
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Motor Mount 
Base & Tray Holders 
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Tray 
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Appendix E – User Manual 
Prepare autoclaved tools & materials: 
- Forceps (narrow tip, 450 and/or 900) 
- Forceps (blunt curved tip) 
- Flat spatula (for grease) 
- Aspirator tips 
- 10 cm silicone tube heat shrunk to 1/16” inner diameter female barbed polypropylene luer (x5) 
- Tissue chamber (x5) with stainless steel dowel pin fitted into pinch clamp hole and 
polypropylene female ¼-28 threaded luer mounted into chamber wall 
- Tissue chamber lids (x5) 
- Compression spring (number dependent on number of mechanically conditioned tissue 
chambers in use) 
- Silicone-based high vacuum grease (Dow Corning, Midland, MI) (as needed) 
Non-autoclaved, sterile materials: 
- Latex gloves (as needed) 
- 10 & 25 mL setological pipets (as needed) 
- Sterile Monoject® 1mL TB syringe (x5) 
- 25 cm2 tissue culture flask (x2) 
- 90mm (or larger if preferred) tissue culture dish (x2) 
- 140mm tissue culture dish 
- Culture media (DMEM, 1X with 4.5 g/L glucose, L-glutamine, & sodium pyruvate) (~50 mL) 
- Complete culture media (DMEM, 1X with 4.5 g/L glucose, L-glutamine, & sodium pyruvate – 
modified with 10% FBS, 1% Penicillin/Streptomycin) (~300 mL) 
Tools & materials cleaned with 70% ethanol solution: 
- Pipetter 
- Aspiration hose 
- Base of device (including motors+ cams + syringe holders) 
- Tray of device 
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Incubator Set-up Procedure: 
1.) Spray and wipe down the base component of the device and position in the incubator with the 
motors furthest from, and parallel to, the front of the incubator. 
 
2.) Feed the wires through the hole at the back of the incubator. 
3.) Arrange the switches and power supply on top of or next to the incubator near an electrical 
outlet and away from any liquids. 
4.) Connect the male and female wire connectors (red wires to red wires; black wires to black 
wires), being very careful not to bend any of the pins in the process (if bent, motors may not 
turn on – can be fixed by straightening or pulling on pins). 
     
5.) Plug in the power supply. 
 
99 | P a g e  
 
Ring Loading onto Silicone Tube Procedure: 
*Note – All procedural steps take place within a sterile biosafety cabinet unless otherwise specified. 
Whenever leaving the biosafety hood, be sure to apply 70% ethanol before re-entering to control 
contamination risk. 
1.) Fill base of 140mm tissue culture dish with  ~ 25mL culture media. 
2.) Aspirate media out of tissue ring culture molds. 
3.) Carefully remove tissue rings from culture molds using narrow 90o forceps and submerge in 
tissue culture dish media. 
 
4.) Repeat for all tissue rings. 
5.) Open autoclaved silicone tubing and place within tissue culture dish with tissue rings. 
6.) Using narrow forceps, place tissue ring (arrow) around one open grip of the blunt curved forceps 
and angle blunt curved forceps upwards in media to prevent ring sliding. 
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7.) Use narrow forceps to place the open end of the silicone tubing tightly over the open grip 
containing the tissue ring. 
 
8.) Use narrow forceps to slide the tissue ring (arrow) onto the silicone tube and position it 
approximately 2 cm from the luer. 
       
9.) Let silicone tube and tissue rings remain submerged in culture media while loading other rings 
and samples. 
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10.) Repeat steps 6-9 until 5-6 tissue rings have been successfully loaded ~1 cm apart on the silicone 
tube. 
 
11.) Repeat steps 5-10 until 5 silicone tubes have been loaded with 5-6 tissue rings each (Note – if 
using less tissue chambers, use fewer silicone tubes, lids, and syringes. 
Tissue Chamber Loading Procedure: 
*Note – All procedural steps take place within a sterile biosafety cabinet unless otherwise specified. 
Whenever leaving the biosafety hood, be sure to apply 70% ethanol before re-entering to lessen 
contamination risk. 
1.) Set up biosafety cabinet as seen in Figure # below, adding more tissue chambers if necessary. 
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2.) Fill tissue culture flask with ~25 mL of culture medium using pipetter. 
 
3.) Remove syringe plunger, place compression spring around plunger, and reinsert plunger into the 
syringe barrel. 
 
4.) Depress syringe plunger until spring is fully compressed, insert syringe into tissue culture flask, 
and fill syringe to the 0.9 mL mark on the syringe barrel. 
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5.) Invert the syringe and tap out any extra air bubbles that may exist within the syringe barrel. 
 
6.) Depress the plunger to remove the excess air that floats to the syringe tip during tapping and 
place the syringe in a sterile petri dish. 
 
7.) Fill the tissue chamber with ~25 mL of complete culture medium (with FBS and P/S added). 
8.) Using foreceps, remove a tissue ring loaded silicone tube from the 140 mm culture dish and 
carefully place it into the tissue chamber. 
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9.) Using foreceps, grip the luer attached to the silicone tube and fit in tightly over the luer 
threaded into the chamber wall. 
  
10.) Insert the 1 mL push-connect syringe into the outer opening of the threaded luer in the tissue 
chamber wall. 
11.) Depress the syringe plunger until the compression spring is flush with the plunger head and 
syringe barrel. 
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12.) Use a pair of forceps to hold a pinch clamp in one hand, use the other hand to push the free end 
of the silicone tube through the pinch clamp opening. 
 
13.) Hold the pinch clamp sideways onto the base of the tissue chamber with a pair of forceps with 
one hand, and with your other dominant hand, grip the inside of the silicone tube using narrow 
tipped forceps and pull or slide the silicone tube beyond the clamping point. Be very careful not 
to damage the tubing or pull it more than half a centimeter past the clamping point. 
 
14.) Place the pinch clamp onto the steel dowel at the base of the tissue chamber. 
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15.) Use one hand to pressurize the syringe plunger down to 0.2 mL and the second hand to press 
the pinch clamp closed using a pair of forceps. 
     
16.) Fill the tissue chamber with an additional ~35 mL of complete culture medium (with FBS and P/S 
added). 
17.) Cover the tissue chamber with a sterile lid. 
 
18.) Position the tissue chamber within the tray with the clamp-end nearest to the plastic screws and 
secure the tissue chamber into the base by hand-tightening the screw (can further tighten once 
removed from the biosafety cabinet). 
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19.) Repeat steps 2-19 until all tissue chambers are secured and ready for transport from the 
biosafety cabinet to the incubator. 
20.) Carefully lift the tray by its handles with the syringes pointing away from you and transport it to 
the incubator. 
 
21.) Position the tray within the tray holder, with syringes on top of the syringe holders in the 
incubator. 
22.) Depress the syringe plunger so that it’s flush with the cam, and snap the syringe(s) into place. 
 
23.) Close the incubator doors and switch on the mechanically conditioned tissue chambers. 
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Appendix F – Bill of Materials 
 
